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Cardiovascular diseases (CVD) are major causes of morbidity and mortality 
worldwide. Complications associated with CVD encompass the entire vascular system, 
including blood vessels that supply brain. Impairments to cerebral blood flow (CBF) 
and cerebrovascular function result in increased risk of cognitive impairment, vascular 
dementia and stroke. Identifying interventions that can attenuate the age-related 
decline in CBF and enhance cerebrovascular function are essential, especially in 
individuals at high risk of CVD. Remote ischaemic preconditioning (rIPC), which 
involves cyclical periods of ischaemia-reperfusion applied noninvasively to a limb, 
has been shown to improve measures of peripheral vascular function and 
cardiovascular endpoints when applied acutely (one episode) or repeatedly (e.g. daily, 
3 times per week). There is also emerging evidence that repeated rIPC elicits beneficial 
effects within the cerebral circulation in stroke patients. However, the mechanisms of 
how rIPC can improve cerebrovascular function are unknown. The overreaching aim 
of this thesis was to investigate whether acute and repeated rIPC could enhance 
cerebral and peripheral vascular function in cohorts with increased risk of CVD.  
In a crossover study design, Study 1 aimed to assess the impact of a single acute bout 
of rIPC on cerebrovascular function.  Eleven young healthy (28±4 years) and nine 
individuals at risk of CVD (53±7 years) underwent assessment of cerebrovascular 
function. Using Transcranial Doppler (TCD), markers of cerebrovascular function 
were assessed following either bilateral arm rIPC or sham condition. There was no 
change in middle cerebral artery velocity (MCAv) or blood pressure (BP) during rIPC. 
Application of rIPC did not alter cerebrovascular reactivity (CVR) compared to sham 
(0.002 MCACVC/mmHg, 95%CI= -0.001, 0.005, P=0.24), nor did it affect any 
parameter of dynamic cerebral autoregulation (dCA) (0.028 normalised 
gain%/mmHg-1, 95%CI= -0.080, 0.137, P=0.59). This study suggested that an acute 
bout of rIPC does not influence cerebrovascular function in healthy young individuals 
and older subjects with increased risk for CVD.          
In a randomised control-pilot design, Study 2 aimed to obtain estimates for the change 
in peripheral conduit and cerebrovascular function following a 7-day rIPC intervention. 
Twenty-one type 2 diabetes mellitus (T2DM) patients performed either 7-day daily 
rIPC or control (no rIPC). Peripheral conduit artery function was assessed using flow 
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mediated dilation (FMD) before and after an endothelial ischemia-reperfusion (IR) 
injury. Cerebrovascular function was assessed using TCD to examine dCA (0.10Hz 
squat stand manoeuvres). All measurements were performed at three time points; pre, 
immediately post intervention, and 8 days post intervention. Using pre-intervention 
data as a covariate, the change from pre-post in FMD was 1.3% (95%CI= 0.69, 3.80; 
P=0.09) and 0.23 %/mmHg-1 (95%CI -0.12, 0.59; P=0.18) in dCA normalised gain 
with rIPC versus control. The directional changes outline FMD can be enhanced by 
daily rIPC in patients with T2DM, whilst cerebrovascular function is unaltered.   
In Study 3, in a randomised design, nineteen participants at risk of CVD were allocated 
into either 8 weeks of aerobic exercise training and rIPC (rIPC +  Ex) or 8 weeks of 
rIPC only performed 3 times per week. Assessment of cerebrovascular function was 
performed using TCD and FMD was used to examine peripheral vascular function 
before and after an IR injury. Measurements were performed before (week 0) and 
immediately after (week 8) each intervention. Neither intervention changed resting 
CBFv, dCA (spontaneous or forced BP oscillations) or CVR. FMD increased by 1.6% 
(95% CI= 0.4, 2.8) in the rIPC + Ex intervention and by 0.3% (95% CI= -1.1, 1.5) in 
the rIPC only intervention, whilst no statistical difference was found between 
interventions (P=0.65). Data from this study suggests that combining exercise with 
rIPC does not result in greater changes in cerebral or peripheral vascular function.                
In Study 4, dCA and baroreflex sensitivity (BRS) data collected during 0.10Hz squat 
stands manoeuvres was obtained from 206 individuals and analysed using transfer 
function analysis.  Cross-sectional associations between ages were examined using 
linear regression adjusting for sex. Multivariable linear regression was used to adjust 
for sex, health status and VO2max. Age, sex, CVD risk and VO2max do not impact on 
dCA parameters normalised gain, phase or coherence (P>0.05). dCA (absolute) gain 
reduced with age when adjusting for sex, and CVD risk. The data from this study 
suggest that dCA parameters, when adjusted for BP, does not decline with age in either 
sex. 
Collectively, the data contained within this thesis suggests rIPC interventions appear 
to be effective in improving peripheral endothelial function, but have little effect on 
cerebrovascular function. Additionally dCA, a frequently measured marker of 
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Cardiovascular disease (CVD) including cerebrovascular disease is the leading cause 
of death worldwide (Townsend et al., 2016.). Cerebrovascular disease is a general term 
encompassing different disturbances of the vascularisation of the brain (Truelsen et 
al., 2006). The human brain receives ~15% of total cardiac output and uses ~20% of 
oxygen available in order to maintain normal function, therefore tight regulation of 
blood flow and oxygen delivery is essential for survival (Willie et al., 2011). Chronic 
reductions in cerebral blood flow (CBF) and the mechanisms regulating stable CBF, 
referred to as cerebrovascular function, are associated with neurodegenerative diseases 
including dementia and Alzheimer’s disease as well as stroke (Yonas et al., 1993, 
Mazza et al., 2011, Leijenaar et al., 2017). Interventions that target increasing CBF 
along with improving cerebrovascular function are essential in reducing the risk of 
cerebrovascular diseases. Ischaemic preconditioning (IPC) refers to non-lethal bouts 
of ischemia followed by reperfusion. IPC is a powerful technique that can protect the 
heart and the vasculature against prolonged ischemia (Thijssen et al., 2016a). There is 
emerging evidence within the last decade suggesting it can exert a positive effect on 
the cerebral circulation (Meng et al., 2012, Meng et al., 2015, Mi et al., 2016, Wang 
et al., 2017).   
The beneficial effects of IPC have been observed in the heart and the conduit arteries, 
i.e. at remote locations to where the ischemia-reperfusion stimulus was applied, which 
is termed remote IPC (rIPC) (Przyklenk et al., 1993). Importantly, application of rIPC 
can be performed non-invasively using a pressure cuff on limbs and still induces 
ischaemic protection (Kharbanda et al., 2001). Typically, a rIPC bout consists of 4 x 
5 minute periods of limb cuff occlusion (ischemia) separated by 5 minutes of cuff 
deflation (reperfusion). Despite the frequently examined impact of rIPC on coronary 
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arteries, few studies have examined the impact of an acute bout of rIPC on 
cerebrovascular function. Therefore, aim 1 of this thesis was to identify whether an 
acute bout of rIPC increases CBF velocity (CBFv) or improve a marker of 
cerebrovascular function in young healthy and/or individuals with risk factors for 
CVD.          
Increasing the ‘dose’ of the rIPC, may in theory provide longer or potent effects 
(Whittaker and Przyklenk, 2014) and this concept has been investigated by performing 
rIPC repeatedly as an intervention (Thijssen et al., 2016a), however few studies 
examined the human cerebrovasculature. The few studies that have employed repeated 
rIPC interventions and focused on cerebrovascular outcomes have identified positive 
clinical outcomes in stroke patients and individuals with cerebral small vessel disease 
following the rIPC interventions (Meng et al., 2012, Meng et al., 2015, Mi et al., 2016, 
Wang et al., 2017).  Whether these positive changes, which included increases in CBF 
and reduction in stroke reoccurrence, are related to improvements in the functional 
control of CBF (cerebrovascular function) is currently unknown. Individuals with 
Type 2 diabetes mellitus (T2DM) are at significantly higher risk of cerebrovascular 
disease and stroke (Chen et al., 2015) and are associated with impairments in vascular 
endothelial function (Hamilton and Watts, 2013).  To date, one repeated rIPC 
intervention in T2DM proved effective in reducing the size of the diabetic foot ulcer 
over 6 weeks (Shaked et al., 2015), but little is known about the impact of daily rIPC 
on cerebrovascular function and peripheral vascular function in T2DM. Consequently, 
aim 2 of this thesis was to implement a 7-day daily rIPC intervention in patients with 
T2DM and assess changes in cerebrovascular function. . 
The length of an rIPC intervention (in duration and frequency of rIPC bouts) might be 
related to a its effectiveness on the vascular system (Thijssen et al., 2016a). Indeed 
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rIPC interventions up to 1 year long have resulted in positive clinical outcomes (Meng 
et al., 2012, Mi et al., 2016). Recent work demonstrated that exercise has a potential 
preconditioning capacity. This allows for the opportunity to increase the 
preconditioning stimulus by combining IPC with exercise training. Incorporating an 
exercise training programme, alongside an rIPC intervention may add an additional, 
but not mutually exclusive, preconditioning stimulus for the vascular system. 
Accordingly, the combination of ischaemic and exercise preconditioning may increase 
the beneficial adaptations observed with repeated rIPC alone. Therefore, aim 3 of this 
thesis was to investigate whether 8 weeks of aerobic exercise combined with repeated 
rIPC could enhance cerebral and peripheral vascular function more than repeated rIPC 
alone in individuals with increased risk of CVD. 
The regulation of stable CBF during changes in blood pressure (BP), termed dynamic 
cerebral autoregulation (dCA), represents an important functional marker of cerebral 
blood vessels regulating CBF (Willie et al., 2011) and is assessed in each study chapter 
of this thesis. Despite the growing body of literature, little is known about how age, 
sex and various CVD risk factors affect dCA. Similarly, there is currently conflicting 
evidence within the literature as to the mechanisms involved in dCA and to what extent 
control of BP, assessed with cardiac baroreflex sensitivity (BRS), is related to dCA. 
By identifying impairments in dCA, which can render the brain vulnerable to hyper- 
or hypoperfusion (van Beek et al., 2008), and understanding the contribution of cardiac 
BRS on dCA, appropriate interventions can then be developed to improving potential 
impairments or limitations. Therefore, aim 4 of this thesis was identify whether age, 
sex, cardio-respiratory fitness or CVD risk factors impact dCA and the contribution of 




1.1 Aims  
 
The specific aims of this thesis are to:  
1. To assess the impact of bilateral arm rIPC on resting cerebral blood flow 
velocity, dynamic cerebral autoregulation and cerebrovascular carbon dioxide 
(CO2) reactivity compared to a sham condition in both young healthy 
individuals and older individuals at risk of CVD. 
2. Obtain estimates of the change in cerebrovascular function and peripheral 
conduit artery endothelial function before and after endothelial ischemia 
reperfusion (IR) injury following 7-days of daily limb rIPC in patients with 
type 2 diabetes. 
3. Examine whether 8 weeks of exercise combined with repeated rIPC could 
enhance cerebrovascular and conduit artery function more than repeated rIPC 
alone in individuals with increased risk of cardiovascular disease. 
4. Identify using squat stand manoeuvers and transfer function analysis whether 
age, sex, cardio-respiratory fitness or CVD risk factors impact dynamic 
cerebral autoregulation and the role of the cardiac baroreceptors. 
1.2 Objectives  
 
The aims outlined above will be achieved through the following objectives: 
In line with Aim 1: 
1. Utilising transcranial Doppler ultrasound, assess cerebral blood flow velocity 
during and following a bout of rIPC.  
2. Compare the effects of acute rIPC vs a sham procedure on cerebral 
autoregulation and cerebrovascular CO2 reactivity. 
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3. Identify whether acute rIPC can reduce the impairment to cerebral 
autoregulation induced by hypercapnia.  
4. Identify if the effects of rIPC differ between the young healthy individuals and 
those at high risk of CVD. 
In line with Aim 2: 
5. Compare the effects of 7 days of daily upper arm rIPC versus non-rIPC control 
on conduit artery endothelial function before and after an induced temporary 
ischaemia reperfusion injury in patients with T2DM.  
6. Compare the effects of 7 days of daily upper arm rIPC on cerebral blood flow 
velocity and dynamic cerebral autoregulation. 
7. Establish if the effects of 7 days of daily rIPC are still present 8 days following 
the end of the intervention.   
In line with Aim 3: 
8. Engage individuals with increased risk of CVD in either an 8-week supervised 
moderate intensity aerobic exercise programme plus rIPC 3 times per week or 
8 weeks of rIPC 3 times per week only.  
9. Compare the effects of combining exercise training with rIPC verses rIPC 
alone on cardio-respiratory fitness, cerebral blood flow velocity and dynamic 
cerebral autoregulation and conduit artery endothelial function before and after 
an induced temporary ischaemia reperfusion injury. 
In line with Aim 4: 
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10. Establish whether dynamic cerebral autoregulation is affected by age, sex, 
fitness and a number of cardiovascular disease risk factors in a large cohort of 
individuals aged 18-70 years.  
11. Identify if there is a relationship between cardiac baroreceptor function and 


















































The focus of this literature review is two-fold; firstly, to outline cerebrovascular 
function measurements, the links with peripheral vascular function and the associated 
changes in the vasculature following interventions. Secondly, to introduce the concept 
of remote ischaemic preconditioning (rIPC), highlight the protective effects of rIPC 
on the heart and peripheral vessels and describe the potential impact of repeated rIPC 
as an intervention on the peripheral and cerebral vasculature.  
 
2.1 The Cerebrovasculature and Cerebrovascular Function 
 
2.1.1 Anatomy of the Cerebral Vasculature  
 
Blood flow to the brain is supplied via four large extra-cranial arteries bilaterally; the 
internal carotid (ICA) and vertebral arteries (VA). Approximately 70% of total 
cerebral blood flow (CBF) is supplied through the ICA’s, with the remaining ~30% of 
total CBF being delivered by the two VA’s (Willie et al., 2014). The ICA continues 
upwards to the base of the brain to form the anterior (ACA) and middle (MCA) 
cerebral arteries bilaterally, whilst the basilar artery bifurcates to eventually form the 
posterior cerebral arteries (PCA) (Figure 2.1). The anterior circulation begins distal to 
the carotid sinus and supplies both the forebrain (frontal and parietal lobes) and 
midbrain (temporal lobes) on both left and right hemispheres. The ICA has a branch 
that feeds the ophthalmic artery, prior to trifurcating to form the MCA, ACA and 
posterior communicating artery. The anterior communicating artery allows the 
anterior circulation to supply both left and right hemispheres by joining the two ACAs. 
The MCA and ACA branches deliver blood throughout the brain through the smaller 
stem and cortical branches which feed into smaller arterioles before eventually feeding 




The posterior circulation arises from the two VAs joining together at the vertebro-
basilar junction to form the basilar artery which supplies the hindbrain regions (brain 
stem and cerebellum) and the occipital cortices. The cerebral circulation is joined in a 
number of locations, which forms the vascular structure termed the Circle of Willis. 
This anatomical ring situated at the base of the brain connects the anterior and 





















Figure 2.1: Anatomy of the cerebrovasculature including intra and extra cranial 
vessels. Abbreviations; Anterior cerebral artery (ACA), Middle cerebral artery (MCA), 
Posterior communicating artery (PCoA), Anterior communicating artery (ACoA), 
Posterior cerebral artery (PCA), Basilar artery (BA), Vertebral artery (VA), Internal 
carotid artery (ICA), left sided artery (L) & right sided artery (R). Adapted from Ren 







2.1.2 Regulation and control of Cerebral Blood Flow 
 
In order to maintain normal functioning, the brain requires constant adequate 
nutritional flow due to its high metabolic demand. In resting conditions the brain is 
accountable for approximately 25% of total oxygen (O2) consumption and receives 
15-20% of total cardiac output (Q) (Franco Folino, 2007), a remarkable amount given 
the brain accounts for approximately 2% of total body mass. Despite the high 
metabolic demand, the brain has a very limited ability to store energy, therefore CBF 
needs to be highly regulated in order to maintain a constant supply of nutrients and O2 
(Peters et al., 2004). CBF is determined by cerebral perfusion pressure (CPP) and 
cerebrovascular resistance (Ainslie and Duffin, 2009, Tzeng and Ainslie, 2014). CPP 
is the difference in BP and intracranial pressure (ICP), with the latter formed from 
central venous pressure and pressures within the cerebrospinal fluid (Ainslie and 
Duffin, 2009). Cerebrovascular resistance refers to the resistant forces acting on blood 
flow through the brain. Resistance to flow occurs mostly in the cerebral arteries and 
capillary beds, with increasing vascular tone in turn increasing resistance (Ainslie and 
Duffin, 2009).  
 
Measurement of CBF can provide information of the functional status of blood vessels 
supplying the brain. The non-invasive nature and high temporal resolution make 
transcranial Doppler (TCD) ultrasound an ideal instrument for the assessment of 
cerebral blood flow velocties (CBFv), in centermeters per second (cm.s-1) as reviewed 
in detail by Willie et al. (2011). TCD was first used in 1982, and has since been 
extensively used in order to assess CBFv (Aaslid et al., 1982). The basic principle of 
TCD ultrasound is a transmitter emitting pulsed ultrasound waves from a Doppler 
probe at 2 MHz. Due to its thin acoutic window, the ultrasound waves are transmitted 
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through the temporal region of the cranium to assess a vessel of interest. The 
assessment of CBFv is derived from the Doppler shift, created by the reflection of 
ultrasound waves from moving erythrocytes (red blood cells) within the blood vessel 
that are returned to the receiver unit in the Doppler probe. Simply, the Doppler shift 
refers to the difference between the transmitted and received ultrasound signals 
(Aaslid, 1986), with faster erythrocyte movement associated with higher velocities, 
and by extension, blood flow. Using TCD, the ACA, MCA and PCA can be assessed, 
in addition to the Basillar artery and Vertebral arteries. Vessels can be insonated from 
four different accoustic windows; Transorbital, Transtemporal, Submandibular and 
Transforaminal (Figure 2.2). 
 
 
Figure 2.2: Acoustic windows used in order to insonate cerebral blood vessels.  
 
Vessel identifcation is achieved based on knowledge of anatomical structure of the 
circle of Willis. (Willie et al., 2011). Understanding of isonation depths and flow 
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direction of the vessel of interest is vital in order to aquire reliable and valid signals 
(Table 1.1).  Additionally, certain stimuli can be applied in order to confirm correct 
vessel isonation including; carotid artery compression will result in reduction in 
MCAv, whereas PCAv will remain largerly unchanged. In addition, PCAv will 
increase by 15-20% with activation of occitital lobe (eyes open-eyes closed) whereas 
MCAv will have small response to this stimulus (<5%). Typically, the MCAs are used 
to examine CBF and cerebrovascular function as they account for ~80% of total CBF 
and have the closest proximity to the temporal window (Skow et al., 2013).  
 
Table 1.1: Typical patterns for identification of cerebral arteries using Transcranial 
Doppler ultrasound 
Abbreviations; Anterior cerebral artery (ACA), Middle cerebral artery (MCA), 
Posterior cerebral artery (PCA).  
 
    
The regulation of CBF is an integrative and complex process with a number of 
mechanisms involved including; BP (cerebral autoregulation), cerebral metabolism 
(neurovascular coupling), chemical control (cerebrovascular reactivity) and 
autonomic nervous system (Willie et al., 2011, Willie et al., 2012, Willie et al., 2014).  














ACA Anterior 60-75 Away Flow reversal Increased 
velocity 
MCA Perpendicular 35-60 Toward Reduced 
velocity 
No change 







2.1.3 Blood Pressure (Cerebral Autoregulation) 
 
Autoregulation of CBF refers to the brain’s intrinsic ability to maintain a relatively 
constant blood flow despite changes in arterial BP. The autoregulatory response to 
changes in arterial BP protects against brain injury caused by potential hyper- or 
hypoperfusion. Indeed, evidence shows that brain injury does occur when 
autoregulatory mechanisms are lost (Novak et al., 1998, Euser and Cipolla, 2007). 
This pressure-flow relationship was noted as early as 1895, when Bayliss, Hill and 
Gulland concluded that ‘In all physiological conditions a rise in arterial pressure 
accelerated the flow of blood through the brain, and a fall slackens it’ (Bayliss et al., 
1895). In 1959 Lassen published a review plotting average BPs and related total CBF 
from seven studies, including 11 different patient groups. Lassen identified that there 
appears to be a plateau region, whereby CBF appears to be stable across a wide range 
of BPs (60-150 mmHg) (Lassen, 1959). More recent studies have established that the 
regulation of CBF is more pressure passive than originally suggested by Lassen (1959), 
with evidence now showing a 0.82 % ΔCBF/ mmHg ΔMAP-1 (Lucas et al., 2010). 
Subsequently, this so called ‘autoregulatory plateau’ outlined by Lassen (1959) may 
not exist, or in fact exists but within a considerably smaller range (± 5-10 mmHg from 




Figure 2.3: Representation of the classical (left) and modern (right) interpretation of 
cerebral autoregulation. Red dotted lines represent the original ‘autoregulatory plateau’ 
(left) and the modern interpretation (right). Blue dotted lines represent cerebrovascular 
resistance; black dotted line represents stable cerebral blood flow; black solid line 
represents cerebral blood changes. Adapted from (Willie et al., 2014)  
 
Cerebral autoregulation can be classified into static (sCA) or dynamic (dCA). sCA 
refers CBF responses to long-term (minutes) changes in BP whereas dCA refers to 
acute (seconds) changes (Aaslid et al., 1989, Tiecks et al., 1995). Assessment of dCA 
has arisen from the ability to monitor beat-to-beat changes in cerebral blood flow 
velocity (CBFv) and mean arterial pressure (MAP) concurrently (Willie et al., 2014).  
Adequate CBF is maintained across a range of BPs due to changes in cerebrovascular 
resistance. Vasodilation occurs in response to decreases in BP and vasoconstriction as 
a result of increase in BP within the upper and lower limits of autoregulation (Figure 
2.4) (Pires et al., 2013). The functions together ensure sufficient blood flow reaches in 
the brain (Willie et al., 2014). Fascinatingly, it appears that cerebral vascular resistance 
is more effective at maintaining CBF during increases in CBF compared to decreases, 
however this difference is lost when studies corrected for changes in PaCO2 (Numan 





Figure 2.4: Cerebral blood flow in relation to artery lumen diameter. Dotted lines 
represent the lower and upper limits of cerebral autoregulation. Red circles represent 
the cerebral arteries, and blue line represents cerebral blood flow. Adapted from (Pires 
et al., 2013).  
 
The underlying mechanism(s) controlling this pressure-flow relationship remains 
unclear and are likely to differ with increases vs decrease in BP. It is likely that these 
mechanisms are multifactorial and include neurogenic, metabolic, myogenic and 
endothelial factors (Tzeng and Ainslie, 2014) and impairment has been observed in 
some clinical conditions.  A reduction in autoregulation (rate of regulation) has been 
reported in T2DM (Vianna et al., 2015), acute ischaemic stroke (Eames et al., 2002) 
obstructive sleep apena (Urbano et al., 2008) and  sporadic Alzheimer’s disease (den 
Abeelen et al., 2014). When patients display impaired cerebral autoregulation, the 
brain may be excessively sensitive to any changes in arterial BP and a failure to the 
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autoregulatory response has been associated with increased morbidity and mortality 
(Hu et al., 2008).  
The mechanism(s) controlling dCA are still largely unknown but are believed to vary 
depending on the frequency range in which the changes in arterial BP occur. A number 
of studies have attempted to investigate the underlying mechanisms primarily using 
blockades and a number of interesting observations have been made. In the very low 
frequency (VLF: <0.07 Hz), this is thought to be under the influence of myogenic 
properties as shown by studies using cholinergic blockades (Hamner et al., 2012, Tan 
et al., 2013) and ganglion blockade (Zhang et al., 2002).  Within an intermediate 
frequency range; low frequency (LF; 0.07-0.20 Hz), is controlled by more sympathetic 
influences, as demonstrated by sympathetic agonist drugs midazolam (Ogawa et al., 
2010) and antagonist drugs prazosin (Purkayastha et al., 2013). The highest frequency 
(HF; >0.20) range, the range in which CBF is most poorly regulated is largely under 
the control of normal respiration rate (Reinhard et al., 2003).  Nevertheless, clear and 
definitive answers to the mechanism controlling dCA still require significant 
investigations. The relationship between myogenic, sympathetic and local neuronal 
mechanisms and their control of dCA is uncertain and new innovative measurement 
methods are required to unlock the true controlling mechanisms.      
Despite the growing interest in assessing dCA the question remains as to the exact 
location in which the regulation takes places. Dilation and constriction has been shown 
to occur in pial vessels in response to fluctuations in BP (Fog, 1938, Lassen, 1959). 
On the other hand, there is data to suggest that larger cerebral arteries respond to the 
changes in BP as well as the extra cranial vessels within the neck (Heistad et al., 1978, 
Kontos et al., 1978). Studies to investigate the main site(s) of dCA are however 
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extremely difficult to perform in humans. Future studies employing advanced imaging 
techniques are required to answer such questions.         
Typical assessment of dCA is carried out with the combined use of TCD and finger 
photoplethysmography. In order to examine the dynamic response between CBFv and 
BP, transient changes in BP are induced. Whilst there is no ‘gold standard’ method 
available for the assessment of dCA  (Panerai, 1998), a number of techniques have 
been previously used to achieve these rapid fluctuations in BP. Instant deflation of 
bilateral thigh cuffs after a period of inflation to supra-systolic levels was used to 
induce transient decreases in BP (Sorond et al., 2009), however this technique is 
associated with high levels of discomfort as well as a variability in the levels of BP 
change with each cuff deflation. More recently, a simple squat to stand (or sit to stand) 
procedure has been found to produce transient changes in BP, yet with less discomfort 
than the bilateral thigh cuffs (Lipsitz et al., 2000). Repeated squat-stand manoevers 
has now emerged a popular method to assess dCA and has been performed in a range 
of clincal and older populations (Claassen et al., 2009a, Aengevaeren et al., 2013, 
Oudegeest-Sander et al., 2014, Smirl et al., 2014a, Lewis et al., 2019) and is 
representative of BP fluctations experienced in daily life (Simpson and Claassen, 
2018).  
  
2.1.3.1 Baroreflex Sensitivity   
 
Both dCA and baroreflex sensitivity (BRS) are key mechanisms that maintain stable 
CBF (de Heus et al., 2018). The baroreflex regulates BP via baroreceptors which 
detect changes in arterial BP. BRS reflects the complex interaction between autonomic 
and vascular function to manage BP fluctuations (Subramanian et al., 2019). The 
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baroreceptors (stretch receptors in the walls of the aorta and carotid artery) send 
signals via the vagus and glossopharyngeal nerves to the Nucleus Tractus Solitarius 
when a rise or drop in BP is detected which results in either increased vagal nerve 
activity and a reduction in sympathetic activity or vice versa, in order to maintain BP 
(Parati and Bilo, 2012). Importantly, BRS carries prognostic value in the development 
and progression of a number of cardiovascular diseases (CVD) including; 
hypertension, coronary artery disease, myocardial infarction and heart failure, with 
sympathetic-parasympathetic imbalances contributing to the complications (La 
Rovere et al., 2008). The assessment of BRS can be performed using several different 
techniques which have been reviewed in detail (La Rovere et al., 2008). 
Pharmacological techniques involve the infusion of vasoactive drugs to induce BP 
changes whilst monitoring heart rate.  A popular none-invasive method includes the 
neck chamber technique which specifically manipulates the carotid baroreceptors 
(Fadel et al., 2003), whereas cardiac BRS can be assessed using the relationship 
between R-R interval and systolic BP (Zhang et al., 2009, Dutoit et al., 2010, 
Aengevaeren et al., 2013).  Evidence suggests that cardiac BRS provides a good 
estimate of overall baroreflex function when measurements of sympathetic outflow 
are unavailable (Taylor et al., 2015) and has been validated against the Modified 
Oxford technique (Horsman et al., 2013) which is often referred to as the ‘gold 
standard’ method of BRS assessment (Gasch et al., 2011, Hissen et al., 2018).   
Impairment to cardiac BRS may lead to orthostatic hypotension which can result in 
cerebral hypoperfusion or syncope (Zhang et al., 2009). Some (Tzeng et al., 2010, 
Witter et al., 2017), but not all (Aengevaeren et al., 2013, Xing et al., 2017) studies 
have observed an inverse relationship between cardiac BRS and dCA. Identifying the 
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relationship between BRS and dCA represents the fourth aim of this thesis and is 
presented in chapter 6.  
 
2.1.4 Cerebral metabolism (neurovascular coupling) 
 
CBF is closely linked to metabolic activity as activations of regions of the brain result 
in changes to local CBF (Willie et al., 2014). This relationship between neural activity 
and CBF is termed neurovascular coupling (NVC), and whilst the coupling between 
neural activity and increases in blood flow is well known, the exact underlying 
mechanisms are still not fully understood (Phillips et al., 2016). Cerebral blood vessels 
are structurally unique and different from other arteries based on their close 
relationship with neurons and glia. The close relationship is between the smooth 
muscle of the vessel walls, the neuron and the astrocyte glial cell together form what 
is known as the neurovascular unit. NVC is impaired in certain pathological conditions 
such as ischaemic stroke, Alzheimer’s and hypertension (Girouard and Iadecola, 2006, 
Lefferts et al., 2018), resulting in the CBF response not meeting the metabolic 
requirement of the tissue.  
Whilst the relationship between brain neural activity and CBF has been known for 
over a century (Roy and Sherrington, 1890), the mechanisms responsible for this 
response are not fully understood. When the supply of oxygen, glucose and other 
nutrients required by the brain are adequate, the smooth muscle cells and pericytes are 
thought to be in a state of basal tone (Muoio et al., 2014). Activation of the neuron 
sends a signal to the astrocyte via the release of glutamate, increasing calcium with 
the astrocyte. This causes a reaction within the astrocyte that in turn leads to the release 
of vasoactive substances from the end-feet causing pericytes and vascular smooth 
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muscle cells to hyperpolarise. The hyperpolarisation of these cells initiates either 
vasodilation (release or NO, adenosine or arachidonic acids) or vasoconstriction 
(release of endothelin or thromboxane) of the local cells (Muoio et al., 2014). The 
change in local vascular tone regulates a change in local vascular resistance, increasing 
or decreasing CBF.  
 
2.1.5 Chemical Control (Cerebrovascular Reactivity) 
 
The partial pressure of arterial carbon dixoide (PaCO2) has a sigificant impact on CBF. 
An increase in PaCO2 (hypercapnia) results in cerebral arteriolar vasodilation, whereas 
a decrease in PaCO2 (hypocapnia) will cause vasocontriction reducing CBF (Ainslie 
and Duffin, 2009). This highly sensitive relationship between changes in PaCO2 and 
CBF responses is termed cerebrovascular CO2 reactivity (CVR) and is recognised as 
a crucial homestoatic function that helps maintain and regulate central pH and cellular 
function (Ainslie and Duffin, 2009). This response can be viewed as a defence 
mechanism, whereby elevations in PaCO2 leads to an increase in CBF in an attempt to 
“wash out” CO2 from brain tissue. Consequently, the increase in CBF contributes to 
normalising or reducing the rise in PaCO2. Typically, the slope of cerebrovascular 
response to CO2 is approximately 3-6% increase per mmHg in PaCO2 above rest and 
1-3% reduction per mmHg decrease below resting values (Willie et al., 2012). This 
means that the cerebrovasculature is more sensitive to a given increase in PaCO2 
compared to a decrease in PaCO2.  It has been suggested that this lower responsiveness 
to hypocapnia (compared to hypercapnia) may be a protective mechanism to avoid 
cerebral ischaemia during reductions in PaCO2, which do occur in a number of 
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physiological conditions (e.g. exercise or change in posture) as well as 
pathophysiological (syncope) (Ainslie and Duffin, 2009).  
The term CVR reflects an index of the ability of the cerebral vessels to dilate or 
constrict in response to changes in arterial blood gases content, typically CO2. It is 
believed that this serves as a control mechanims for respiration-induced changes in 
CO2. Within the brainstem respiratory chemoreceptors are present which are highly 
sensitive to alterations in pH. CVR to changes in CO2 has been applied in clinical 
practice to evalute cerebrovascular function. One large scale project ‘The Rotterdam 
Study’ demonstrated in a cohort of 1695 participants, lower cerebral reactivity to 5% 
CO2 stimulus was assosiated with increased risk of all-cause death (Portegies et al., 
2014). In addition, lower response to a CO2 stimulus has been observed in patients 
with; Alzheimers (den Abeelen et al., 2014), multiple sclerosis (Marshall et al., 2014) 
and heart failure (Georgiadis et al., 2000). Clinically, this impairment may represent 
dysfunction from a number of mechanistic inputs. The mechanims responsible for the 
role of CO2 in regulating vascular tone and pH are not fully identified. Activation of 
potassium (K+) channels in the vascular smooth muscle is a potential mechanism 
which has received attention given its ability to relax (dilate) cerebral vessels (Ainslie 
and Duffin, 2009). Additionally, nitric oxide (NO) and prostaglandins may play a role 
in the hypercapnic induced vasodilation as a result of increased shear stress (Ainslie 
and Duffin, 2009) and that an individuals reponse to CO2 depends on the intergrity of 
the vascular endothelium (Ainslie et al., 2007). Indeed, mechanistic studies have 
identfitied the role of shear-stress mediated vasodilation as a result of increased CO2 
suggesting the use of such measurements to quanify cerebrovascular endothelial 
function  (Carter et al., 2016, Hoiland et al., 2017).  
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The cerebrovasculature is not only sensitive to changes in CO2, but oxygen (O2) also 
plays a role in vascular tone. Hypoxia effects the cerebrovasculature, but only when 
PaO2 levels drop below ~50mmHg (Willie et al., 2012, Willie et al., 2014). Acute 
hypoxia induces increases in CBF before plateauing (Harris et al., 2013) and the 
impact of hypoxia on cerebral autoregulation is still debated (Subudhi et al., 2010, 
Smirl et al., 2014b).  The response to hypoxia however is still affected by CO2 given 
that studies have shown it is the ventilatory response to the hypoxia which ultimiately 
determines the CBF response, as hypercapnia increase and hypocapnia decreases the 
sensitivity of the cerebrovasculare to hypoxia (Mardimae et al., 2012, Willie et al., 
2014).  
CVR has typically been assessed in one of three potential ways. The earliest technique 
used was breath holding, whereby participants would hold their breath in order to 
progressively increase PaCO2. This technique has a number of limitations. First, 
individual variability between individuals in factors such as; gender, size of lungs, age 
all affected the CBF response to breathe holding (Fierstra et al., 2013). A second 
potential strategy relates to the rebreathing of exhaled gas, which became and remains 
a common technique to achieve increases in PaCO2. This method requires minimal 
equipment with just an exhaled gas reservoir and gas sensors necessary. Limitations 
to this strategy is that rebreathing of exhaled gas causes a ramp-like response with 
each breath causing an increase in PaCO2. This prevents performing a stable 
measurement of increased CBF. A third and final strategy is the use of external CO2 
supplied to a participant by means of a non-rebreathing face mask, with inspired CO2 
concentrations ranging from 2-7% (Fierstra et al., 2013). This method is favourable as 
it can induce a standardised hypercapnic stimulus (Vernieri et al., 2004) and is used 
throughout this thesis. 
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2.1.6 Cerebral and Peripheral vascular function 
 
Functional markers of the cerebral and peripheral circulations can change 
simultaneously. Improvements in cerebral and peripheral vascular function are seen 
with exercise training (Bailey et al., 2013, Tarumi et al., 2015) and reductions in both 
have been observed with Alzheimer’s and stroke (Silvestrini et al., 2006, Dede et al., 
2007). Collectively, assessment of cerebral and peripheral vascular function is 
important in providing a representation for systemic vascular function. However, 
impairment in one artery does not seem interchangeably with changes in another artery. 
The endothelium is a single layer of cells that forms the inner lining of the entire 
circulatory system. Once considered a passive layer of inert cells, the vascular 
endothelium is now known to be highly biologically active. The endothelium occupies 
a strategically important location between the circulating blood and vessel wall and 
has the ability to respond to changes in its physical, chemical or humoral environment 
(Rubanyi, 1993). The endothelium continuously produces the freely diffusible gas 
nitric oxide (NO) at a low basal rate, which helps maintain the health of the vessel 
wall and regulate vascular tone. NO is a potent anti-atherogenic molecule, inhibiting 
platelet and leukocyte adhesion and a powerful vasodilator (Green et al., 2011). 
Increases in blood flow, therefore increases in intimal shear stress (the fricitional drag 
force exerted by the blood flow on the arterial wall), represents the physioloigcal 
stimulus for the release of NO (Pohl et al., 1986). 
Assessment of peripheral vascular function can be performed non-invasively on 
peripheral conduit arteries using the flow mediated dilation (FMD) technique 
(Celermajer et al., 1992). The dilation that occurs during an FMD can be significantly 
attenuated/abolished using NO blockade  (Joannides et al., 1995, Lieberman et al., 
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1996, Mullen et al., 2001, Kooijman et al., 2008), making the FMD a largely NO-
dependent test of endothelial function,  Collectively, the evidence from these 
physiological studies reinforces the validity of the technique as an assessment of 
endothelium dependent and NO-specific index of endothelial function (Thijssen et al., 
2011). FMD is reduced with CVD risk factors, relates to coronary artery endothelial 
function, and independently predicts CVD outcomes (Thijssen et al., 2019b). 
Additionally, it is recognised as a reproducible technique in examining the acute and 
long-term impact of physiological and pharmacological interventions in humans 
(Thijssen et al., 2011, Thijssen et al., 2019b). 
2.1.7 Interventions targeting cerebral and peripheral function 
 
2.1.7.1 Cerebrovascular function  
 
Reductions in cerebrovascular function are strongly associated with clinical conditions, 
whilst pharmacological approaches represent some of the interventional strategies to 
enhance CBF, CBFv and cerebrovascular function. For the purpose of this thesis, 
studies focusing on cardio-respiratory fitness and exercise interventions are 
summarised below.        
2.1.7.2 Exercise training in healthy humans 
 
Humans display a natural age-related decline in CBF, however evidence does show 
that maintaining high cardiorespiratory fitness does attenuate this age-related decline 
(Ainslie et al., 2008b). This maintenance of CBF could potentially explain lower rates 
of cerebrovascular disease/incidents in individuals that are physically more active 
(Ainslie et al., 2008b). A small number of studies have implemented structured 
exercise interventions in an attempt to increase CBF and improve cerebrovascular 
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function or attenuate the age-related decline, but the results are conflicting. Eight 
weeks of moderate aerobic cycling evoked an increase in CBFv in postmenopausal 
women (Akazawa et al., 2012), whilst others found 8-12 weeks of aerobic exercise 
does not induces changes in CBFv in healthy young and older individuals (Murrell et 
al., 2013, Lewis et al., 2019). A 6 week HIIT intervention in endurance trained men 
resulted in no change in CBFv and a slight reduction in dCA (Drapeau et al., 2019). 
This reduction in dCA with elevated cardio-respiratory fitness has been noted in a 
small number of other studies (Labrecque et al., 2017, Labrecque et al., 2019a), which 
is somewhat confusing given that elevated cardio-respiratory fitness has been linked 
to increased CBFv (Ainslie et al., 2008b) and better CVR (Bailey et al., 2013). Taken 
together, various factors, including intervention duration, exercise type and intensity, 
and population contribute to whether exercise training changes CBFv and 
cerebrovascular function. Furthermore, functional markers of the cerebrovascular 
system appear to respond differently to exercise training, strongly suggesting a need 
for further research to understand exercise training (Barnes and Corkery, 2018).  
 
2.1.7.3 Exercise training in clinical populations 
 
As outlined in section 2.1, reductions in CBF and cerebrovascular function often 
manifest in various patient cohorts. Therefore, exercise interventions, which have the 
potential to improve both may be of greater importance for individuals at increased 
CVD risk. A small number of studies have examined the impact of exercise training 
on CBF and cerebrovascular function in clinical groups. Eight weeks of aerobic 
training in patients with chronic obstructive pulmonary resulted in no change in 
cerebrovascular function (dCA & CVR) or CBFv (Lewis et al., 2019), whilst in 
individuals with mild cognitive impairment, 12 weeks of moderate aerobic training 
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lead to increased CBF and cognitive function (Alfini et al., 2019). Stroke survivors 
following 6 months of aerobic treadmill exercise improved CVR (Ivey et al., 2011) 
yet no such changes were evident following 18 weeks of training in congestive heart 
failure patients (Tanne et al., 2005).  The patient population being assessed in each 
study may represent a critical factor as to whether the exercise intervention improves 
CBF or functional markers. Another factor that may influence the impact of exercise 
training on CBF is the duration of the intervention, especially as increase in CBF was 
typically found in those adopting a longer period of training. It is clear that more 
research is warranted to understand possible beneficial effects of exercise on 
cerebrovascular health in clinical and preclinical populations.  
 
2.1.7.4 Peripheral vascular function  
   
As outlined in section 2.1.6, peripheral vascular function is frequently used as a marker 
for systemic endothelial function (Thijssen et al., 2019b). Impaired peripheral vascular 
function (endothelial dysfunction), in the form of reduced FMD has been associated 
with conditions predisposing atherosclerosis and CVD (Charakida et al., 2010). The 
following sub section will summarise the literature that employed exercise 
interventions to change peripheral vascular function in healthy and clinical 
populations   
 
2.1.7.5 Exercise training in healthy humans 
 
Peripheral vascular function measured using FMD demonstrates a progressive decline 
with age as the result of reduced NO bioavailability (Celermajer et al., 1994, Thijssen 
et al., 2016b). However, a recent meta-analysis which pooled data from 14 studies 
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concluded that long-term aerobic exercise appears to attenuate the age related decline 
in FMD (Campbell et al., 2019). In young healthy individuals, a number of studies 
have shown that short-term exercise training increases vascular function (FMD) 
(Green et al., 2004, Tinken et al., 2010, Birk et al., 2012, Schreuder et al., 2015) with 
prolonged training inducing structural adaptations (i.e. increased artery diameter) 
(Green et al., 2012, Green et al., 2014b). This sequence of functional improvements 
preceding structural changes appears now to be a consistent observation. Studies 
involving 2-weekly measurements across an 8-week period of large (i.e. 
cycling/running exercise) (Tinken et al., 2008, Birk et al., 2012) or small muscle group 
(i.e. handgrip exercise) (Tinken et al., 2010) training in healthy young volunteers have 
consistently demonstrated that 2 weeks of exercise training is sufficient to 
significantly enhance vascular function. This initial rapid increase in vascular function 
is often normalized after 6–8 weeks of training as arterial structural remodelling occurs 
(Tinken et al., 2008, Green et al., 2017). These observations support the idea that 
exercise training leads to time-dependent adaptation in conduit artery function, which 
is superseded by arterial remodelling (Schreuder et al., 2015). 
 
2.1.7.6 Exercise training in clinical populations 
 
Vascular endothelial dysfunction is present in various clinical and pre-clinical groups 
such as hypertension, obesity and T2DM (Widmer and Lerman, 2014). Exercise 
represents an intervention that has numerous physiological benefits including 
improved endothelial function. Brachial artery FMD was enhanced following 8 weeks 
of aerobic training in patients with T2DM (Schreuder et al., 2015), with a similar 12 
week intervention improving FMD in adolescents with T2DM (Naylor et al., 2016).  
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Numerous systematic reviews and meta-analysis have been performed concluding 
exercise improves peripheral vascular function in heart failure (Pearson and Smart, 
2017), T2DM (Qiu et al., 2018), cancer survivor (Beaudry et al., 2018) and obese (Dias 
et al., 2015) patients. Different exercise types have evoked vascular improvements, 
with an 8-week HITT intervention increasing FMD in a cohort of obese individuals 
(Sawyer et al., 2016) and interestingly Boff et al concluding that HITT was more 
effective in improving FMD compared to moderate training in patients with type 1 
diabetes (Boff et al., 2019).           
 
In summary, tight regulation of CBF is essential in maintaining normal functioning 
and reducing the risk of cerebrovascular disease/complications. Nevertheless, the 
impact of exercise interventions on cerebrovascular function is unclear in both healthy 
and diseased groups. Unlike the changes in peripheral vascular function, measuring 
using FMD, that on balance suggest positive peripheral vascular functional changes 
with exercise training. Therefore, alternative or additional interventions might provide 
a larger stimulus to improve cerebrovascular function.    
2.2 Ischaemic Preconditioning  
 
In 1986, investigators discovered that brief intermittent episodes of ischaemia had 
protective effects on the myocardium that was later subject to a sustained bout of 
ischaemia (Murry et al., 1986). Murry and co were the first to identify the phenomenon 
known as ischaemic preconditioning (IPC) which involved 5 minutes of canine left 
anterior descending coronary artery occlusion, followed by 5 minutes of reperfusion 
repeated 4 times. Evidence of cardioprotective effects following IPC was supported 
when a number of follow-up studies confirmed their original observations (Li et al., 
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1990, Murry et al., 1990, Murry et al., 1991, Ovize et al., 1992). These data contributed 
to the concept that exposure to (non-lethal) cardiac ischaemia in the period preceding 
coronary ischaemia may protect against the impact of reperfusion of the occluded 
artery on the magnitude of myocardial damage.  
2.2.1 Remote IPC 
 
Przyklenk and colleagues performed a landmark study in 1993, in which they 
demonstrated that cyclical ischaemia and reperfusion of the circumflex coronary artery 
was associated with protection of cardiac territory supplied by the left anterior 
descending artery (i.e. an area remote from the preconditioning stimulus of the 
circumflex coronary artery) (Przyklenk et al., 1993). These findings from Przyklenk’s 
group provided the first evidence demonstrating the effects of what is now termed 
‘remote’ ischaemic preconditioning (rIPC).  
Preclinical studies investigating the impact of rIPC on the heart have classically 
collected perfusate from animals who have been subject to IPC. When naive hearts 
have subsequently been perfused using a Langendorff preparation, a number of studies 
have identified that in both the donor heart subject to the IPC and the naive recipient 
heart that has received the perfusate from the preconditioned donor, infarction size 
was significantly smaller following a prolonged ischaemic event (Dickson et al., 1999, 
Huffman et al., 2008).  These finding demonstrated the ability of rIPC to reduce the 
damage induced by ischaemic injury in remote areas, potentially through a blood-
borne pathway.  Intriguingly, evidence has shown the rIPC can provide protection 
between-species, since rabbit hearts displayed protection against a prolonged bout of 
cardiac ischaemia when perfused with human preconditioned serum (Shimizu et al., 
2009, Michelsen et al., 2012). This suggested a similarity in the factors conferring 
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protection across species, and that such agent/s remain conserved during such 
procedures, allowing binding to the recipient receptors.          
Clinical human studies exploring the effects of rIPC have typically applied the rIPC 
cycles using a blood pressure cuff on a limb, before (planned) prolonged myocardial 
ischaemia. A small number of studies have investigated the use of rIPC in patients 
undergoing coronary artery bypass graft (CABG) or percutaneous coronary 
interventions (PCI), as these procedures involve global myocardial ischaemia (and 
subsequently cardiac damage) as shown by elevated cardiac troponins post-procedure. 
Consequently, strategies that can attenuate the damage as a result of global myocardial 
ischaemia have clinical relevance. Meta-analyses (Brevoord et al., 2012, D'Ascenzo 
et al., 2012) have identified lower peri-postoperative levels of troponins in patients 
undergoing CABG and PCI if rIPC is applied. More importantly, evidence suggests 
that rIPC may reduce overall perioperative myocardial infarction (Thielmann et al., 
2013, Candilio et al., 2015). For example, Thielmann et al. (2013), demonstrated in 
329 patients undergoing CABG proceeding a bout of rIPC, reduced post-CABG 
troponin concentrations and also lowered all-cause mortality after a 1.5 year follow-
up. Therefore, rIPC may in turn provide long-term clinical benefits to humans.     
 
In 2010, Bøtker and colleagues explored this concept in humans by randomizing 
patients with suspected acute myocardial infarction to a rIPC group or control group 
during transition to hospital (Botker et al., 2010). They identified that rIPC on 
transition along with standard treatment was associated with better myocardial salvage, 
assessed by myocardial perfusion imaging, compared to standard care alone. 
Intriguingly, a follow-up performed on the same patient group approximately 3.8 years 
later reported that the rIPC treated patients experienced fewer major adverse cardiac 
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and cerebrovascular effects (Sloth et al., 2014). Whereas it is important to present the 
evidence of the beneficial effects of rIPC, it is also essential to acknowledge the work 
that has found no positive clinical impact. In a large scale randomised control trial 
including 1612 patients undergoing CABG, rIPC did not improve clinical outcomes 
in patients (Hausenloy et al., 2015), with a similar observation in patient requiring 
cardiopulmonary bypass for cardiac surgery (Meybohm et al., 2015) 
 
Whilst the beneficial effects of rIPC on the cardiovascular system has attracted 
attention, its effect on the cerebrovascular system has certainly received less. 
Nevertheless, there is a growing body of animal research that supports the notion that 
rIPC provides protection against ischaemic injuries in the cerebrovascular system and 
provides neuroprotection. This is of clinical relevance as brain ischaemia is one of the 
leading causes of morbidity and mortality in the world (Liu et al., 2009). Hoyte et al., 
(2006) conducted a study in mice and employed 15 minutes of MCA occlusion 72 
hours prior to inducing a 45-minute injurious cerebral ischaemia. They reported an 
increase in regional brain blood flow during the injurious occlusion, measured via 
magnetic resonance perfusion and laser Doppler flowmetry in the mice that received 
the IPC as well as a reduction in infarct size (Hoyte et al., 2006). Ren and colleagues 
extended this work by applying rIPC to the left femoral artery of rodents, 2 days prior 
to inducing cerebral ischaemia. They reported that rIPC was associated with a 
reduction in infarction size compared to the animals with no preconditioning (Ren et 
al., 2008). Jensen and colleagues also observed that pigs who received rIPC to the limb, 
displayed an accelerated recovery in neurological function and ECG pattern and 
demonstrated a lower brain lactate concentration compared to controls following 
ischaemic injury as a result of hypothermic circulatory arrest (Jensen et al., 2011).  
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These data provide evidence that (r)IPC can offer cerebrovascular and neural 
protection against cerebral ischaemia. Nevertheless, research in humans is warranted 
to be able to translate this into clinical practice. This will be the focus of study 1 within 
the current thesis. 
2.2.1.1 Ischaemia-reperfusion injuries  
 
When arterial blood flow is blocked, it is essential that blood flow is restored in order 
to prevent irreversible tissue damage. When organs become ischaemic, the deprivation 
of blood flow and oxygen have long been recognised as the critical factor in clinical 
outcomes. However, the reperfusion phase (restoring of blood flow) is not without 
consequence and induces even further cellular damage that is greater than the damage 
caused by the ischaemia itself (Eltzschig and Collard, 2004). Evidence for this was 
shown when 3 hours of ischaemia followed by 1 hour of reperfusion induced cellular 
damage that exceeded that of the damage caused by a 4 hour ischaemic protocol (Parks 
and Granger, 1986). Cellular damage induced by the reperfusion phase following a 
period of ischaemia is referred to as ischemia reperfusion injury (IRI).  IRI can occur 
in a variety of clinical scenarios; thrombolytic therapy, organ transplant, coronary 
angioplasty, cardiopulmonary bypass or aortic clamping (Eltzschig and Collard, 2004) 
as well in cardiovascular events/disorders such as; myocardial infarction, stroke and 
peripheral vascular disease (Kalogeris et al., 2012). This highlights the clinical 
relevance to minimise IRI.  
Ischaemia promotes a proinflammatory state that intensifies tissue vulnerability to any 
further damage during reperfusion. The extent of the injury caused by a period of 
ischaemia is heavily influenced by the duration of the blood flow restriction (Eltzschig 
and Collard, 2004) and crucially the organ in which is affected by the ischaemia, with 
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the brain being the most sensitive organ to reductions in blood supply (Ordy et al., 
1993).  When reperfusion occurs following ischaemia, levels of oxygen are rapidly 
restored and the extracellular pH returns to normal. Even with this restoration of 
oxygen and extracellular pH, the intracellular pH remains acidic and this pH gradient 
facilitates extrusion of H+ from the cell in exchange for Na+ (Murphy and Steenbergen, 
2008). Additionally, increases in ROS during ischaemia and re-oxygenation is 
believed to be due to damage to components of the electron transport chain resulting 
in inefficient transfer of electrons resulting in the generation of superoxides. The 
significant increase in ROS production induces further oxidative damage to cellular 
structures (Murphy and Steenbergen, 2008). IRI occurs in a wide range of organs 
including the heart, gut, kidney, lung, skeletal muscle and brain and may involve not 
only the ischaemic organ itself but may also induce systemic damage to distant organs, 
potentially leading to multi-system organ failure. Reperfusion injury is a multi-
factorial process resulting in extensive tissue destruction and vascular interventions to 
improve IRI outcomes are important. A growing body of evidence suggests that rIPC 
has the ability to reduce the level of cellular tissue damage following an IRI, both 
planned or unplanned (Heusch et al., 2015). 
 
2.2.2 Repeated rIPC interventions 
 
The ‘traditional’ doses of rIPC applied in the majority of studies have principally used 
4 x 5 minutes of occlusion followed by reperfusion. Whittaker and Przyklenk outlined 
the potential use of repeated rIPC, referring to this traditional dose (4x5 minutes) but 
applied more often (e.g. daily or weekly) (Whittaker and Przyklenk, 2014). Given the 
potent effects of a single dose of rIPC, repeated episodes may, in theory, provide 
longer or more potent reduction of ischaemic myocardial damage (Whittaker and 
35 
 
Przyklenk, 2014). Table 2.1 provides a summary of all human studies to do date that 
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2.2.2.1 The myocardium  
 
Only a relatively small number of studies on repeated rIPC have focused directly on 
the myocardium and the ability of episodic rIPC to impact the magnitude of 
myocardial damage. For example, 40 patients with coronary artery disease who were 
scheduled for CABG surgery were randomized to a 20 day period of repeated rIPC 
(three rIPC sessions daily, n = 20) or a control intervention before surgery (n = 20). 
Patients undergoing repeated rIPC demonstrated   approximately 50% lower troponin 
expression levels after CABG compared with the control group (Liang et al., 2015). 
The ability of repeated rIPC to reduce postoperative cardiac troponin is in line with 
previous work on single rIPC scheduled before CABG.  Wei et al. (2011) explored 
different protocols of rIPC in rats undergoing planned cardiac ischaemia, including a 
single episode of rIPC and repeated (every 3 days versus daily) rIPC across 28 days 
post-injury. Although the reduction in infarct size on days 4 and 28 was comparable 
across the protocols, repeated rIPC was associated with a dose-dependent protection 
against adverse remodelling and improved survival. In parallel with these findings, 
work from Yamaguchi et al. (2015) divided rats post-myocardial infarction into a 4 
week repeated rIPC group and a control group and reported that repeated rIPC prevents 
adverse cardiac remodelling (and fibrosis in the boundary region).  
A short one week rIPC intervention, consisting of twice-daily unilateral arm rIPC 
increased coronary flow reserve, through improvements to coronary microcirculation 
in both healthy participants as well as in patients with heart failure (left ventricle 
ejection fraction <40%) (Kono et al., 2014), suggesting the potential use of daily rIPC 
in the lives of patients with heart failure. Additionally, a 28 day rIPC intervention 
consisting of daily limb rIPC in patients with chronic ischaemic heart failure 
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demonstrated a significant reduction in systolic BP, the N-terminal pro-brain 
natriuretic peptide (as a marker of heart failure) and improved global longitudinal 
strain in patients with the most severe heart failure (Pryds et al., 2017) 
The potential effects of repeated rIPC are not isolated to reducing the magnitude of 
cardiac damage following prolonged ischaemia. Repeated rIPC interventions appear 
to also have an effect on vascular endothelial function. Given that previous work has 
demonstrated that improvements in peripheral and coronary vascular function is 
related to lower risk for future cardiovascular events (Green et al., 2011), this is of 
particular importance.    
2.2.2.2 The peripheral vasculature  
 
Kimura et al. (2007) were the first to examine the effects of repeated rIPC following 
28 days of rIPC on forearm resistance artery endothelial function in healthy 
individuals. They provided evidence that repeated rIPC improved resistance artery 
endothelial function via increase in NO production and numbers of endothelial 
progenitor cells (EPCs). Luca et al. (2013) followed this work by exploring if repeated 
(daily) rIPC altered the efficacy of a single bout of rIPC against an induced ischaemia-
reperfusion injury. In line with their hypothesis, daily rIPC provided more sustained 
protection against an endothelial IRI compared to a single bout, measured with FMD. 
More recently, these findings of enhanced vascular endothelial function were extended 
when it was found that 7 days of daily rIPC improved both brachial artery FMD and 
skin perfusion (microvascular function), whilst these benefits were evident in the 
ipsilateral (exposed to IPC stimulus) and the contralateral arm (remote location to rIPC 
stimulus) (Jones et al., 2014). Importantly, these effects of the repeated rIPC 
intervention persisted for 7 days after the end of the intervention, suggesting that 
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improvements are related to a more prolonged adaptation rather than a transient 























Figure 2.5: (A) Brachial artery flow-mediated dilation (FMD); expressed as a 
percentage and (B) resting forearm cutaneous vascular conductance before (Pre), after 
(Post) and 8 days after (Post+8). the 7 day daily IPC intervention in the IPC (open 
circles) and contralateral arm (filled circles) of healthy volunteers (n = 13). Error bars 





It has been suggested that infarct-sparing effects from rIPC are present for 1–2 h 
following an rIPC episode (early phase), whereas these protective effects return after 
24 h for a period of 3–4 days (late phase) (see section 2.2.4). Although described in 
relation to protection of the ischaemic myocardium, a similar pattern may also be 
found in peripheral vessels. Therefore, repeated rIPC bouts may be timed 24–72 h 
apart to ensure that the tissue will be exposed simultaneously to the ‘early phase’ and 
‘late phase’. Given the relatively long duration of the ‘late’ phase of protection, Jones 
and colleagues explored the impact of less frequent and more spaced rIPC bouts by 
administering rIPC for 8 weeks (3 cycles per week) (Jones et al., 2015). They 
identified that rIPC significantly increased brachial artery FMD and that these 
improvements were apparent after two weeks (six rIPC bouts) in young healthy males. 
The impact of repeated rIPC as an intervention on vascular function, including the 
impact on endothelial IRI, in individuals with vascular dysfunction is currently 
unknown and will be investigated in patients with T2DM in study 2 and CVD risk 
factors in study 3 of the present thesis. 
In support of repeated rIPC having a beneficial impact on those with endothelial 
dysfunction, patients with T2DM have complications which are vascular in nature 
where ischaemia plays a critical role i.e. in the development of diabetic foot ulcers. In 
one study, patients with diabetic foot ulcers were randomised into 6 weeks of bilateral 
(upper limb) rIPC or control group (no rIPC). The ratio of patients who reached 
complete healing of their ulcer was significantly higher in those who received repeated 
rIPC compared with the control group (41 versus 0%, respectively), and the remaining 
ulcer area was smaller (25 versus 61%, respectively) (Shaked et al., 2015). A higher 
42 
 
prevalence of wound healing is of major clinical significance given that 20% of 
patients with diabetic foot ulcers ultimately require amputation (Eldor et al., 2004).    
2.2.2.3 The cerebrovasculature  
 
Research examining the impact of repeated rIPC on cerebrovascular function and 
clinical outcomes in humans is limited. Two large-scale clinical trials have been 
conducted examining the potential benefits of repeated rIPC on human 
cerebrovascular function in patients with intracranial arterial stenosis. The studies 
employed bilateral limb rIPC twice daily for 300 days and found a significant 
reduction in stroke recurrence along with a significant increase in cerebral perfusion 
and improved modified Rankin Scale score (measurement scale for neurological 
disability) (Meng et al., 2012). Remarkably, the same group later observed a 
significant reduction in ischaemic events following a course of 180 days of bilateral 
limb IPC, twice daily, applied within an older population of IAS patients, with no 
adverse changes to heart rate or arterial BP (Meng et al., 2015). Additionally, a one-
year rIPC intervention involving bilateral rIPC twice daily applied to patients with 
cerebral small vessel disease outlined that rIPC can help in slowing down cognitive 
decline as well as reduce white matter hyperintensities (Wang et al., 2017). The use of 
rIPC as an additional treatment for ischaemic stroke has been reviewed in detail 
(Landman et al., 2019), this based on preclinical and clinical evidence demonstrating 
that rIPC is feasible, safe and free of adverse incidents in the clinical populations 
studied thus far. Landman et al discusses how rIPC related to the brain is a few steps 
behind that of cardiology in terms of research and advocates future studies exploring 
rIPC. Whilst the current studies provide indirect evidence that rIPC may have an 
impact on cerebrovascular function in humans, no study to date has directly assessed 
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how the cerebrovasculature is changing to mediate beneficial improvement in stroke 
risk and cognitive function. The focus of studies 2 and 3 in the present thesis will 
investigate the impact of repeated rIPC on cerebrovascular function in individuals with 
CVD risk factors. 
 
2.2.2.4 Phases of rIPC  
 
rIPC has a characteristic temporal nature, involving two independent ‘phases’ of 
protection. The acute phase is believed to arise immediately after the rIPC and 
disappears approximately 2 hours after, and a delayed phase that appears around 24 
hours after the preconditioning stimulus, lasting longer but regarded as less protective 
and potent (Heusch et al., 2015). The acute protection depends on immediate 
recruitment of signalling molecules, whereas increased expression of protective 
proteins is a hallmark of the delayed protection (Bolli et al., 2007). Whilst endogenous 
NO, generated from endothelial and inducible nitric oxide synthase does not seem to 
be involved for immediate protection, it is involved in the delayed protective effects 
of IPC (Bolli et al., 1998). The contribution of NO to the late phase of rIPC was further 
supported when a NO synthase inhibitors abolished the impact of rIPC in an animal 
model (Takano et al., 1998). Expression of other cardioprotective proteins has also 
been shown to be unregulated during the delayed protection (e.g. cyclo-oxygenase-2, 
superoxide dismutase (Zhou et al., 1996, Guo et al., 2000). These effects on the 
upregulation of (cardioprotective) proteins may contribute to the sustainability of the 
IPC stimulus and vascular adaptation (Thijssen et al., 2016a). Therefore, repetitive 
upregulation of these proteins, usually noted during the delayed/late protective phase, 
may be of relevance in understanding the effects of repeated IPC on sustainable 
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improvement in vascular function. Whether these effects actually translate to the 
peripheral and/or cerebral vascular beds, also taking into consideration the presence 
of potential deleterious remodelling, is currently unknown. 
An alternative explanation for the local effects/adaptations to vascular function 
induced by rIPC may relate to the changes in haemodynamics. The repeated exposure 
to the ischaemia-reperfusion cycle causes elevations in blood flow (shear stress) 
during each reperfusion phase. Repeated episodes of increases in shear stress are 
recognised as an important stimulus in vascular adaptations given that such 
adaptations are not evident when shear stress is attenuated (Green et al., 2010, Tinken 
et al., 2010).  
2.2.2.5 Potential mechanisms of (r)IPC and repeated rIPC 
 
Whilst their remains no definitive mechanism identified for the cardioprotective and 
vascular effects of rIPC, there has been a number of potential mechanisms proposed. 
It is important to acknowledge that there may be differences in the mechanisms 
responsible for benefits of a single bout of rIPC and repeated rIPC interventions 
(Thijssen et al., 2016a). It is also important to acknowledge that identifying the 
mechanisms of rIPC is not the focus of this thesis. In-depth reviews related to potential 
mediating mechanisms have been published (Hausenloy and Yellon, 2008, Heusch et 
al., 2015, Thijssen et al., 2016a). A summary of potential mechanisms is provided 
below.    
The classical view of the protective effects of rIPC relates to the following cascade; a 
trigger is released (in the occluded limb) and acts as a stimulus to activate a mediator, 
which in turn transmits a protective signal onto an effector that attenuates injury in 
45 
 
remote location (vascular and cardiac) in to response to ischaemia-reperfusion. The 
activation of these pathways is highly complex and is likely to involve the input of 
multiple signals in order to confer the protection (Hausenloy and Yellon, 2008, Heusch 
et al., 2015, Thijssen et al., 2016a).  
The episodes of rIPC applied to the limb induce subsequent transduction of the local 
signal to the remote tissue (or organ), but is dependent on intact neural and humoral 
pathways (Lim et al., 2010). The autonomic nervous system has been shown to play a 
role in the protective effects of rIPC, given that infusion of Trimethaphan (autonomic 
ganglion blocker) abolished the effects of rIPC on vascular function pre and post IRI 
(Loukogeorgakis et al., 2005). Remarkably, local nerve stimulation appears to have a 
similar effect to rIPC on cardioprotection, whereas a nerve blocker of the peripheral 
nerve abolished that protection (Redington et al., 2012). With regards to cerebral 
protection conferred by rIPC, evidence again suggests a neural component. Several 
studies have demonstrated blockades of sensory inputs attenuate the 
beneficial/protective effects of rIPC in animal models (Malhotra et al., 2011, Wei et 
al., 2012).  
Cardioprotection from rIPC is also mediated through circulating, blood-borne 
hormones that are able to protect remote (cardio)vascular regions against prolonged 
ischaemia (Dickson et al., 1999), with recent evidence supporting a potential role for 
NO, microRNA-144 and stromal-derived factor 1α (SDF-1α) (Heusch et al., 2015). In 
the target organ, signal transduction pathways are activated that ultimately contribute 
to the protection against ischaemic injury. In the heart, signal transduction of RIPC 
‘shares’ that of local IPC, with at least significant involvement of NO (and endothelial 
nitric oxide synthase), protein kinase C and the RISK pathway that ultimately work 
on the mitochondria (Heusch et al., 2015).  
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The production of circulating hormones represents one logical mechanism that might 
contribute to the effects of repeated IPC on both the ability to ameliorate damage after 
prolonged ischaemia and the sustained adaptation in remote vascular function. The 
role of circulating hormones in the protection against myocardial injury was first 
highlighted by (Dickson et al., 1999) who found that coronary effluent from a 
preconditioned heart induced cardioprotection in a naïve acceptor heart.  Subsequently, 
several studies adopting the Langendorff model suggested the presence of a blood-
borne substance that confers protection when infused in an organ exposed to prolonged 
ischaemia. Despite the scientific and clinical importance, identifying the substance or 




In summary, tight regulation of CBF and the mechanims controlling CBF (i.e. 
cerebrovascular function) is essential in reducing the risk of cerebrovascular disease. 
rIPC is a technique which has shown potential in improving a number of 
cardiovascular parameters. The majority of the research has focused on 
cardioprotection against IR injuries, whilst only a very small number of studies have 
explored the use of rIPC as intervention to improve parameters within the cerebral 
circulation. Nonetheless, these latter studies report remarkably positive clinical 
outcomes in a cohort of patients with history of cerebrovascular complications (Meng 
et al., 2012, Meng et al., 2015, Mi et al., 2016, Wang et al., 2017). Yet, no study has 
investigated whether and/or how rIPC, applied either acutely or repeatedly, is effective 
in enhancing CBF via improvements in cerebrovascular function in individuals at risk 








Chapter 3: The impact of acute remote 













3.1 Introduction  
 
Remote ischaemic preconditioning (rIPC) is a technique that offers enhanced hypoxic 
tolerance and protection to systemic organs and tissues following repeated brief 
periods of ischaemia and reperfusion to a remote vascular bed (Lim and Hausenloy, 
2012). This phenomenon, mediated via a neural and/or humoral pathway (Shimizu et 
al., 2009, Jensen et al., 2012), was first described in canine hearts (Przyklenk et al., 
1993) with subsequent studies demonstrating its efficacy in humans. More 
specifically, rIPC has been reported to reduce cardiovascular events in patients 
following coronary artery bypass and percutaneous coronary intervention surgeries 
(Thielmann et al., Davies et al., 2013a), and reduce brachial artery endothelial 
ischemia reperfusion damage (Kharbanda et al., 2002). Given these broad potent 
protective effects, it is possible that rIPC may also affect the brain and cerebral 
vasculature. 
 
Animal studies have reported rIPC-mediated neuroprotection in the form of reduced 
infarct size and improved neurological recovery following prolonged cerebral 
ischaemia and hypothermic circulatory arrest (Ren et al., 2008, Jensen et al., 2011). 
Extending these findings to humans, a study in stroke survivors reported increased 
cerebral perfusion and 70% lower stroke recurrence following daily rIPC for 300 days, 
compared to a group of patients receiving standard care (Meng et al., 2012). This 
protective effect was reinforced in a recent study in acute stroke patients where 
repeated application of rIPC significantly improved clinical status and reduced 
National Institutes of Health Stroke Scale scores (England et al., 2017), while rIPC 
was found to significantly reduce white matter hyperintensities volume in small vessel 
disease patients (Wang et al., 2017). Strict regulation of brain blood flow is crucial for 
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the maintenance of cerebrovascular health and is impaired in numerous clinical 
groups, including stroke survivors. Based on previous observations that repeated rIPC 
improves peripheral macro- and microvascular health in humans (Kharbanda et al., 
2002, Jones et al., 2015), the observed benefits of rIPC on cerebrovascular health may 
be related to acute improvements in cerebrovascular function in vivo. Assessing the 
impact of rIPC on cerebrovascular function would i) extend the fundamental 
understanding of the acute effects of RIPC in humans, and ii) may provide insight into 
how rIPC mediates neuroprotection and further establish it as a novel therapeutic 
strategy in clinically vulnerable groups.   
 
The primary aim of this proof of principle study was to assess the impact of bilateral 
arm rIPC on resting CBFv, dCA and CVR to carbon dioxide (CO2) in healthy 
individuals, compared to a sham condition. To examine the effectiveness of rIPC 
across a broader spectrum of vascular health, also included were participants at an 
increased risk for CVD and stroke. Finally, previous studies have reported that 
hypercapnia (induced by inhalation of higher concentrations of CO2) transiently 
disrupts dCA and has been used as a model for impaired cerebral autoregulation 
(Zhang et al., 1998, Panerai et al., 1999, Ainslie et al., 2008a, Jeong et al., 2016). 
Therefore, the secondary aim of this study was to assess the ability of rIPC to attenuate 
hypercapnia-induced impairment of dCA. It was hypothesised that rIPC would 
improve dCA and CVR, while attenuating the hypercapnia-induced impairment in 
dCA, when compared to a sham condition in both young healthy individuals and those 








3.2.1 Participants  
 
Twenty participants were recruited for the study (Healthy; n=11 [Females n=6] and 
CVD risk; n=9 [Females n=4], Table 3.1).  Healthy young participants (age; 
28.1±3.7yrs) were recreationally active, engaged in low to moderate intensity exercise 
2-3 days per week, and were free from cardiovascular diseases, including diabetes, 
hypertension or hypercholesterolemia. For the second group, older individuals 
(52.5±6.7 yrs) with cardiovascular risk factors were recruited based on having ≥1 of 
the following criteria; body mass index >30kg/m2 or a waist circumference ≥94cm 
(male), ≥80cm (female), blood pressure systolic >130/diastolic >85 mmHg or 
diagnosed with high cholesterol (total >200 mg/dL, triglycerides >150 mg/dL, LDL 
>100 mg/dL).  Smokers, individuals with previous angina or myocardial infarction, 
transient ischaemic attack or stroke and thrombosis were excluded from participation. 
Participants were informed of the study protocol verbally and in writing before 
providing written informed consent. The study was approved by the University 
Research Ethics Committee (16/SPS/019) and adhered to the standards set out in the 











Table 3.1: Participant characteristics. 
 
Characteristics Healthy individuals CVD risk individuals P Value 
 n=11; Female=6 n=9; Female=4  
Age (years) 28 ± 4 53 ± 7 <0.001 
Height (cm) 173.1 ± 10.1 169.4 ± 10.3 0.44 
Weight (kg) 71.7 ± 13.6 93.6 ± 23.9 0.02 
BMI (kg/m2) 24 ± 3 32 ± 6 <0.001 
MAP (mmHg) 89 ± 4 104 ± 3 <0.001 
PetCO2 (mmHg) 37.8 ± 2.0 40.2 ± 2.9 0.10 
MCAv (cm.s-1) 70 ± 15 54 ± 8 0.02 
 
Values are means ± SD. BMI; body mass index, MAP, mean arterial pressure; PetCO2; 




3.2.2 Research Design  
 
Participants attended the laboratory on two occasions (separated by a minimum of 3 
days). All tests were performed at the same time of day to control for diurnal variation 
in cerebrovascular function (Ainslie et al., 2007). All participants arrived at the 
laboratory for testing following an overnight fast and had refrained from alcohol, 
exercise and caffeine for 24h prior to each visit. Visits were randomised and 
counterbalanced to receive either the bilateral upper arm rIPC or the sham condition. 
Each visit consisted of the bilateral assessment of MCAv during rIPC or sham.  
Following this cerebral autoregulation was assessed using a 5 min squat-stand protocol 
(0.10 Hz). This was then proceeded by a 5 minute rest period, followed by 4 minutes 
of hypercapnia (5% CO2) and then another 5 minute squat-stand (0.10 Hz) protocol 
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but whilst breathing 5% CO2 (Figure 3.1). The phase of menstrual cycle was not 
controlled for in the female participants. 
 
Figure 3.1: Schematic of the protocol for each testing visit.  
 
 
3.2.3 Measurements  
 
Remote ischaemic preconditioning and sham. The rIPC condition consisted of 8 bouts 
in total involving the inflation of a pneumatic cuff (Hokanson SC10D; USA) on the 
upper arm using a rapid inflator (EC-20; D.E Hokanson) to 220 mmHg for 5 minutes.  
Cuffs were inflated in an alternating fashion allowing for one arm to be occluded while 
the contralateral arm underwent reperfusion. The sham condition consisted of the 
identical protocol with the difference that the cuff pressure was inflated to only 10 
mmHg.  
 
Cerebral blood flow (middle cerebral artery blood velocity). Following 20 minutes 
rest in the supine position, bilateral MCAv’s were continuously measured through the 
temporal window using TCD. Two 2-MHz Doppler probes (Spencer Technologies, 
Seattle, USA) were adjusted until an optimal signal was identified and held in place 
using a Marc 600 head frame (Spencer Technologies, Seattle, USA). Once the optimal 
MCAv signal was attained, the probe location and machine settings (depth, gain and 
Rest
RIPC
















power) were recorded to identify the same imaging site for the second testing session. 
Participants were instrumented with a two-way valve mouthpiece (Hans Rudolph) 
from which end tidal CO2 (PETCO2) was measured using a calibrated gas analyser 
(ML206 ADinstruments, Colorado Springs, USA). Continuous beat-by-beat blood 
pressure was obtained from a digit (Finapres, Amsterdam, Netherlands) and heart rate 
acquired from a 3 lead electrocardiogram. All data was sampled at 50 Hz with the data 
acquisition system PowerLab via the interface LabChart 7 (ADinstruments, Colorado 
Springs, USA). 
 
Cerebral autoregulation. Dynamic cerebral autoregulation (dCA) was assessed using 
a squat-to-stand procedure that induces transient changes in arterial blood pressure 
(Claassen et al., 2009b, Smirl et al., 2015). Participants replicated the experimenter 
whilst performing the manoeuvres, that involved moving from a standing upright 
position to squatting until the legs achieved a 90° angle. Participants performed two 
sets at 0.10 Hz (5 second squat - 5 second stand) while breathing normal atmospheric 
air, and again during hypercapnia (detailed below). The first set of squat-stands was 
preceded by 5 mins of seated rest while the second set immediately followed the 4 
mins of hypercapnia. Squat stand manoeuvres were performed at 0.10 Hz as this falls 
within a frequency range whereby cerebral autoregulation is deemed to be active 
(Zhang et al., 1998, Smirl et al., 2015) and represents a more feasible challenge than 
0.05 Hz manoeuvres, especially for those in the CVD risk factor group. 
Carbon dioxide reactivity. Following a rest period of 5 mins, a baseline measurement 
of cerebral blood velocity, MAP and PETCO2 was performed across 2 mins while 
participants breathed in room air. Following the baseline period, the inhaled air was 
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switched to a Douglas bag (100L) containing 5% CO2, 21% oxygen and balanced 
nitrogen, while participants sat in a rested seated position. 
 
Data analysis: MCAv and MAP during the 40 min rIPC and sham conditions were 
averaged and extracted from LabChart in 5 min intervals (n=20).  MCA 
cerebrovascular conductance (CbVC) was calculated as MCAv/ MAP.  Calculation of 
the CVR slopes were performed via linear regression analysis of the two time-points; 
baseline (MCAv, MAP, PETCO2 averaged across 2 mins) and 5% CO2 (data averaged 
across the last 30 secs of the 4 min hypercapnia). Two participants in the 
cardiovascular risk factor group were unable to complete the hypercapnic protocol, 
therefore data analysis for CO2 reactivity was performed on n=18 (Healthy=11). 
 
Cerebral autoregulation data were extracted from LabChart beat-to-beat (MAP and 
MCAv) before spline interpolation and were assessed via transfer function analysis 
(TFA) based on the Welch algorithm, using a provided script (http://www.car-
net.org/). The 5 min squat-stand recordings were subdivided into five windows 
overlapping by 50% and passed through a Hanning window before fast Fourier 
transform analysis (MathWorks-Inc., Natick, Massachusetts). The cross-spectrum 
between MAP and MCAv was determined and divided by MAP auto-spectrum to 
formulate functions; normalised gain (nGain), absolute gain, phase and coherence 
(MAP-MCAv linearity). Gain represents the difference in amplitudes between the 
CBFv and BP signals, while phase describes the temporal alignment between the input 
(MAP) and output (MCAv). nGain refers to the same output as gain, except blood flow 
velocity values are normalised by dividing beat-to-beat values by the mean value.  
Gain, nGain and phase data were excluded from statistical analysis if coherence was 
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<0.4.  TFA was performed in accordance with standardised guidelines from the 
Cerebral Autoregulation Research Network (Claassen et al., 2016). TFA parameters 
of the driven oscillations were band averaged across the very low (VLF; 0.02-0.07 
Hz), low (LF; 0.07-0.2 Hz) and high (HF; 0.2-0.4 Hz) frequency domains. Induced BP 
oscillations at 0.10 Hz were employed in the current study, this falls within the ranges 
of the LF domain. Therefore, the low frequency (0.07-0.20 Hz) output is the most 
appropriate to be reported as dCA is highly active with this frequency of squats (Zhang 
et al., 1998).  PETCO2 data was averaged across each 5 min squat-stand recording. One 
participant in the cardiovascular risk factor group was unable to complete the cerebral 
autoregulation protocol during normocapnia while three participants from the same 
group were unable to complete the protocol during hypercapnia, therefore data was 
analysed on n=18 for the normocapnic and n=17 for the hypercapnic cerebral 
autoregulation conditions. 
 
3.2.4 Statistical Analysis 
 
A three-factor group*condition*time (group; healthy vs CVD risk factors, condition: 
rIPC vs sham, time: 5 min intervals during intervention) general linear model was 
employed to analyse resting MCAv and MAP during the RIPC and sham intervention. 
A three-factor -capnia*group*condition (capnia; normocapnic or hypercapnic, group; 
healthy vs CVD risk factors, condition: RIPC vs sham) general linear model was 
employed to analyse the cerebral autoregulation. A two way group*condition (group; 
healthy vs CVD risk factors, condition: RIPC vs sham) general linear model was 
employed to analyse the CO2 reactivity. Statistically significant main effects and 
interactions were followed up with the least significant difference (LSD) approach for 
multiple comparisons. Statistical analysis was conducted using Statistical Package for 
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Social Sciences (Version 22; SPSS Inc., Chicago, IL). Statistical significance was 
delimited at P<0.05. Data are presented in the text as mean (95% confidence interval) 
unless otherwise stated. 
3.3 Results 
 
3.3.1 Group characteristics 
 
Resting MCAv was significantly higher in the healthy compared to CVD risk group 
(Table 3.1, P=0.009), while resting MAP was significantly lower in the healthy 
compared to the CVD risk group (Table 3.1, P=0.001). For resting comparisons of 
cerebrovascular function between the groups, responses to the CO2 reactivity and dCA 
tests during the sham condition are reported. No difference was evident in CO2 
reactivity slopes between the healthy and CVD risk groups at rest (2.15 [1.60, 2.70] 
vs 1.68 [1.13, 2.24] cm/s/mmHg, P=0.44), or for any of the dCA variables. 
3.3.2 Impact of rIPC on resting cerebral blood velocity and haemodynamics 
 
There was no impact of rIPC on MCAv across the 40 min (P=0.58, Figure 3.2). There 
was a group*condition interaction, with MAP being higher during rIPC compared to 
sham in the CVD risk group over the 40 min intervention period (P<0.005), whilst 
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Table 3.2: Dynamic cerebral autoregulation analysis via transfer function using squat-stand 
manoeuvres. Resting comparison of healthy and CVD risk participants. 
 
Sham condition - Normocapnia 
 Healthy  CVD Risk P Value 
PETCO2 (mmHg) 37.46 ± 1.89  40.28 ± 3.19 0.10 
Dynamic Cerebral Autoregulation (0.10 Hz) 
MCAv power (cm.s2) 88.78 ± 39.65  64.89 ± 80.16 0.16 
MAP power 
(mmHg2) 
118.91 ± 50.60  87.01 ± 80.16  0.12 
Normalised gain 
(%.mmHg-1) 
1.25 ± 0.30   1.30 ± 0.20  0.87 
Gain (cm/s/mmHg) 0.84  ± 0.19   0.74 ± 0.12  0.46 
Phase (radians) 0.55 ± 0.37   0.60 ± 0.55 0.89 
Coherence 0.61 ± 0.10   0.67 ± 0.09  0.12 




3.3.3 Impact of rIPC on normocapnic and hypercapnic cerebral autoregulation 
 
During normocapnia, there were no main effects or interactions in the low frequency (0.10 Hz) 
for normalised gain (Table 3.4, P=0.46), phase (P=0.53) or coherence (P=0.59) between the 
sham and rIPC conditions. PetCO2 values during the squat-stand procedure were not different 
between conditions (P=0.81). Similarly, during hypercapnia, no significant main effects or 
interactions in the low frequency domains for normalised gain (Table 3.4, P=0.11), phase 
(P=0.90) or coherence (P=0.45) were observed. PetCO2 values during hypercapnia did not 




3.3.4 Effect of hypercapnia on cerebral autoregulation (comparison of sham conditions) 
 
Hypercapnia induced a phase reduction of 0.15 radians (0.08, 0.34) when compared to 
normocapnic cerebral autoregulation (P=0.002) with no effect of the RIPC or Sham condition 
(P>0.05). Additionally, normalised gain decreased during hypercapnic cerebral autoregulation 
by 0.41% (0.21, 0.47) compared to normocapnic (P<0.001).   
 
 
3.3.5 Impact of rIPC on cerebrovascular CO2 reactivity 
 
The inhalation of 5% CO2 significantly increased PetCO2 following the sham and rIPC 
conditions respectively (Table 3.3, both P<0.001). MCAv subsequently increased, with no 
difference between the sham and rIPC conditions (Table 3.3, P=0.43). There was no overall 
effect of RIPC on CO2 reactivity compared to the sham condition (group x treatment x PetCO2, 
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This is the first study to investigate the acute impact of rIPC on both dynamic cerebral 
autoregulation and cerebrovascular CO2 reactivity in healthy humans and those at 
increased risk of cardiovascular disease and stroke. The principle findings from this 
study are i) resting cerebral blood velocity was significantly higher at baseline in the 
healthy group compared to the cardiovascular risk group and ii) rIPC did not impact 
resting cerebral perfusion, cerebrovascular CO2 reactivity or cerebral autoregulation, 
in either group. These findings extend the fundamental understanding of the acute 
effects of rIPC in humans and reveal that a single episode of rIPC does not 
immediately impact cerebrovascular function in humans. 
Despite the well-documented effects of rIPC on myocardial and peripheral vascular 
function in humans (Bøtker et al., Thielmann et al., Kharbanda et al., 2002, 
Loukogeorgakis et al., 2005, Davies et al., 2013b, Jones et al., 2014), the present study 
is the first to examine the acute impact of rIPC on CBFv, and both dCA and CVR in 
humans. The cerebral tests included in the present study were employed to provoke 
cerebral vasomotion via a number of different regulatory pathways, to better identify 
any specific effect rIPC may have.  In response to 40 mins of upper arm rIPC (4 bouts 
per arm, alternated), no concurrent impact on CBFv was present. Increases in arterial 
diameter and blood flow to limbs and organs (heart) regional to the limb undergoing 
rIPC have been previously reported during the reperfusion phases of rIPC (Zhou et al., 
2007, Enko et al., 2011). The findings in the present study that rIPC did not alter CBFv 
during the bout is an important observation in this context and suggests that rIPC does 
not influence blood vessel function similarly in the brain. Although it is not known 
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what mechanism/s are responsible for the regional changes in blood flow in the 
previous studies during rIPC, it cannot be discounted the possibility that rIPC did 
induce a change in cerebral perfusion, and that this change was counteracted by one 
of the numerous cerebral blood flow regulatory mechanisms (Willie et al., 2014). 
However, consistent with the above finding of no change in blood flow, no overall 
impact on cerebrovascular function was observed. Resting cerebral autoregulation, a 
regulatory mechanism that maintains a constant delivery of oxygenated blood to the 
brain despite changes in blood pressure (Aaslid et al., 1989), was unchanged by rIPC. 
The second aim of this study was to temporarily disturb dCA via hypercapnia to 
determine whether rIPC could attenuate the impairment. As expected (Birch et al., 
1995, Zhang et al., 1998, Panerai et al., 1999, Ainslie et al., 2008a), hypercapnia 
reduced dCA phase (indicating a delayed CA response time), but did not alter absolute 
gain, an effect consistent with some (Ainslie et al., 2008a), but not all studies (Zhang 
et al., 1998, Panerai et al., 1999, Jeong et al., 2016) and interestingly decreased 
normalised gain, an observation which suggests reduced magnitude of BP on CBF 
oscillations which has also been observed during hypercapnic spontaneous oscillations 
(Ainslie et al., 2008a). Hypercapnia is thought to reduce the efficiency of dCA as a 
result of hypercapnic-induced vasodilation, preventing the ability of the blood vessels 
to alter their vasotone in response to blood pressure changes (Perry et al., 2014). 
Investigations that have examined the precise mechanism responsible for hypercapnic 
impaired dCA are limited. Maggio et al. (2013)  outlined that metabolic pathways are 
likely the primary mechanism attenuating dCA from hypercapnia, as shown with 
significant reductions in critical closing pressure, yet these results are limited to 
spontaneous BP oscillations rather than driven.  
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In contrast to the original hypothesis, rIPC did not attenuate the hypercapnia-induced 
impairment in phase (temporal alignment). rIPC did not impact CVR to inhalation of 
5% CO2 compared to the sham condition. Currently, there is only one directly relevant 
study that assessed rIPC and cerebrovascular function via dCA in humans.  Work by 
Guo et al. (2019) identified that dCA, assessed using spontaneous blood pressure 
oscillations as opposed to driven, is improved 6 hours after a rIPC bout, further 
supporting the idea that rIPC adaptations occur in different phases (Thijssen et al., 
2016a). Additionally, Guo and colleagues identified a number of blood biomarkers 
(vascular endothelial growth factor and glial cell derived neurotrophic factor)  that are 
elevated following rIPC, potentially offering an mechanistic explanation for these 
changes (Guo et al., 2019). An additional study using hypoxia rather than hypercapnia 
as a model to attenuate cerebrovascular function measured cerebral blood flow 
responses to acute and chronic hypoxia, and found no effect of rIPC compared to 
controls, findings consistent with the present study (Rieger et al., 2017). Despite this, 
there is increasing evidence that repeated rIPC is neuroprotective, particularly in 
clinical stroke and small vessels disease patients (Meng et al., 2012, Meng et al., 2015, 
Mi et al., 2016, Wang et al., 2017). Meng et al. previously reported that 300 days of 
repeated rIPC decreased stroke recurrence and interestingly noted that cerebral 
perfusion was higher in the rIPC group compared to the standard care patients, 
potentially remedying the mismatch between perfusion and metabolism. This study 
raises the intriguing notion that repeated bouts of rIPC may be required in order to 
influence cerebral perfusion and function to a physiologically relevant extent. 
Additionally, the phenomenon of rIPC-mediated protection is known to be biphasic in 
nature, with an immediate protective period that subsides within a few hours of 
application, followed by a more prolonged second protective window (1-3 days) 
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(Koch et al., 2014). Due to the difficulties in assessing the time-course of rIPC 
effectiveness in humans, the vast majority of these studies have been performed in 
animals.  Although it is unlikely, one possible explanation for the null findings is that 
the cerebral measures were not performed within the initial protective phase, and that 
the protective windows in humans may differ to that of animals, and may also be 
influenced by the type, number and duration of rIPC bouts.  
 
An important aspect to this study was assessing the impact of rIPC across a spectrum 
of cardiovascular health, to determine if this influenced the efficacy of rIPC. Young 
healthy individuals typically present with unimpaired endothelial-vascular function 
and as the magnitude of the rIPC effect on cerebrovascular function, if any, is 
unknown, it is possible that a rIPC effect would not be observable in this population. 
Accordingly, assessment of the effects of rIPC in healthy individuals and those at 
increased cardio- and cerebrovascular risk. As expected, cardiovascular risk metrics 
were significantly different between the groups, with the young healthy individuals 
displaying lower mean arterial pressure and higher resting cerebral blood flows 
compared to the elevated risk individuals. Nonetheless, no differences in the efficacy 
of rIPC to improve cerebral autoregulation under normo- and hypercapnic conditions 




The findings of this study extend the fundamental knowledge on the physiological 
effects of rIPC in humans by assessing for the first time the acute impact of rIPC on 
cerebral perfusion, dCA and CVR. Although acute rIPC has been found to increase 
peripheral blood flow, this study reports that this effect of rIPC does not extend to the 
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cerebral circulation, as no change was observed in cerebral perfusion during rIPC.  
Additionally, rIPC did not influence cerebral function, as measured by dCA and CVR. 
Despite these findings related to a single exposure to rIPC, recent clinical trials show 
that repeated rIPC provides neuroprotection in humans. Therefore, future studies are 
required to better understand whether repeated exposure to the rIPC stimulus leads to 
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Cardiovascular and cerebrovascular disease are leading causes of mortality in T2DM 
(Laakso, 2001). Importantly, the pathological consequences of T2DM predominately 
relate to vascular complications, encompassing both the macro- (e.g. cardio- and 
cerebrovascular disease) and microvasculature (e.g. retinopathy and nephropathy) 
(Orasanu and Plutzky, 2009). Clinical studies show that diabetic individuals are more 
susceptible to ischemia-reperfusion injuries (IRI) compared to non-diabetics (Alegria 
et al., 2007, Marso et al., 2007), and reduced tolerance to ischaemia has been 
considered responsible for the increase morbidity of ischaemic heart disease in T2DM 
(Haffner et al., 1998). Conventionally, the main therapeutic target in T2DM has been 
glucose lowering but the importance of targeting cardiovascular risk is increasingly 
recognised (Creager et al., 2003).  Intensive glucose lowering treatment has shown 
limited benefits on all cause morbidity and mortality from cardiovascular causes 
(Boussageon et al., 2011).  Lifestyle changes including improved diet and physical 
activity are the mainstay of management with regular exercise promoted to improve 
metabolic health and lower cardiovascular and cerebrovascular risk in T2DM (Chudyk 
and Petrella, 2011). Since a vast majority of T2DM patients do not engage in regular 
physical activity (Morrato et al., 2007, Hermann et al., 2014), perhaps because of 
disease complications (e.g. foot ulcers), alternative or adjunct interventions are 
required to improve cardiovascular and cerebrovascular disease risk, similar to that of 
exercise, in this highly vulnerable population.      
 
rIPC is a technique whereby short periods of cyclical tissue ischaemia-reperfusion (of 
a limb) has been shown to have protective effects beyond the vascular bed directly 
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exposed to the IPC stimulus (Przyklenk et al., 1993), potentially mediated by neural 
and/or humoral signalling pathways (Heusch et al., 2015, Thijssen et al., 2016a), yet 
precise mechanisms remain elusive. When applied prior to planned ischaemia (e.g. 
coronary artery bypass surgery) or around spontaneous ischaemic events (e.g. 
myocardial infarction), studies have reported the potential beneficial and protective 
effects of rIPC to render remote (vascular) tissues and organs (e.g. heart) resistant to 
ischaemic reperfusion injuries (Heusch et al., 2015). More recently, studies have 
examined the impact of performing multiple rIPC episodes and explored the potential 
of rIPC as an intervention to improve vascular function (Thijssen et al., 2016a). 
Repeated rIPC interventions ranging from 1 to 8 weeks have been shown to improve 
vascular endothelial function before and after ischemia reperfusion injuries (Luca et 
al., 2013, Jones et al., 2014, Jones et al., 2015), increase the levels of endothelial 
progenitor cells (Kimura et al., 2007), and increase coronary flow reserve in heart 
failure patients (Kono et al., 2014). Some studies have also revealed a potential clinical 
benefit of rIPC with a 6-week intervention reducing the size of diabetic foot ulcers 
(Shaked et al., 2015) and lower stroke recurrence following one year of rIPC (Meng 
et al., 2012, Meng et al., 2015). As outlined in chapter 3 of this thesis, a single bout of 
rIPC applied to a limb did not induce any changes in CBFv, CVR or dCA, and these 
results were identified in both young healthy individuals and those deemed at high risk 
of CVD (see Chapter 3). This raises the fundamental question of whether the amount 
of rIPC applied is a major contributor to the effectiveness of the technique or 
intervention and warrants further investigation. Therefore, whether an acute intensive 
rIPC intervention leads to improvements in cerebrovascular function assessed 
measuring dCA, a key mechanism protecting the brain from fluctuations in BP, as well 
as peripheral endothelial function in T2DM patients is currently unknown, whilst such 
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benefits may have important clinical benefits, especially those with functional 
limitations.  
The primary aim of this pilot study was to obtain estimates of the change in conduit 
artery endothelial function before and after endothelial IRI, a model that allows for the 
assessment of the efficacy of an intervention to reduce the damage that is induced by 
reperfusion following a period of ischaemia, succeeding a 7-day rIPC intervention. 
Acute intensive rIPC interventions have improved conduit artery endothelial function 
(Jones et al., 2014) and attenuated the injury induced by an IRI in young healthy 
individuals (Luca et al., 2013), yet it is not known whether rIPC offers similar benefits 
to individuals with T2DM whereby endothelial dysfunction is likely present (Avogaro 
et al., 2011).     
 
The secondary aim was to obtain estimates of the change in cerebrovascular function 
after 7-days of daily limb rIPC. Given the evidence rIPC has systemic beneficial 
effects on vascular regulation and endothelial function (Kimura et al., 2007, Jones et 
al., 2015), improvements to blood vessel function may translate to enhanced 
responsive to blood pressure within cerebral vessels (dynamic cerebral autoregulation). 
Additionally, application of rIPC can regulate several vasoactive biomarkers including, 
nitric oxide, adenosine and bradykinin (Heusch et al., 2015, Randhawa and Jaggi, 2016) 
which may have the potential to enhance dCA (Takada et al., 2001, Guo et al., 2016, 











Twenty-one participants (13 males, 8 females, Table 4.1) with clinically diagnosed 
T2DM who were managed with diet or metformin only were recruited for this 
randomised controlled pilot study (Figure 4.1). Participants were excluded if they had 
a history of stroke (including TIAs), diagnosis of chronic heart failure, were current 
smokers or were being treated with sulphonylureas, DPPIV, GLP-1, SGLT2 or insulin 
to control T2DM. Participants were informed of the study protocol verbally and in 
writing before providing written informed consent. The study was approved by the 
local NHS ethics committee (14/NW/1208) and adhered to the standards set out in the 
Declaration of Helsinki (2000). All data collection took place at Liverpool John 
Moores University. Registered clinical trial at ClinicalTrials.gov NCT03598855. Trial 






























Table 4.1: Descriptive characteristics of participants in rIPC and control groups (p 
values reported from independent samples t-test). 





Age (years) 59±7 60±10 0.72 
Weight (kg) 92.7±18.6 101.5±32.5 0.62 
BMI (kg/m2) 32±7 34±10 0.89 
MAP (mmHg) 101±14 107±11 0.37 
SBP (mmHg) 145±16 151±19 0.57 
DBP (mmHg) 79±9 84±10 0.31 
Metformin  9/11 4/10  
Anti-hypertensive 
medication 
4/11 0/10  
Lipid lowering medication  7/11 3/11  
 
Values are means ± SD. Abbreviations; BMI, Body Mass Index; MAP, mean arterial 






4.2.2 Research Design 
 
Participants attended the laboratory on three occasions, separated by seven days, 
having fasted overnight (12hrs), refraining from alcohol and exercise for 24hrs and 
caffeine for 12hrs before each visit. Each visit consisted of assessments of brachial 
artery function (before and after ischemia reperfusion injury) and cerebrovascular 
function. Assessments were performed at the same time of day for each visit (Ainslie 
et al., 2007, Jones et al., 2010) and occurred prior to group randomisation (computer-
generated-sequence) (Pre), immediately following the cessation of the intervention 








Figure 4.2: Schematic of the study design. Each rIPC consisted of 4 cycles of 5-
minute ischaemia (220 mmHg) followed by 5 min reperfusion applied unilaterally. At 
each testing visit brachial artery flow mediated dilation, ischaemic reperfusion injury 










Brachial artery endothelial function. Brachial artery endothelial function was assessed 
using the flow mediated dilation (FMD) technique following 20 min of supine rest 
(Thijssen et al., 2011). Images of the right brachial artery were acquired using high-
resolution ultrasound (T3300; Terason, Burlington, MA). Diameter, flow and shear 
stress were measured prior to and following 5 minutes of forearm cuff inflation (D.E. 
Hokanson, Bellevue, WA). All FMD measurements were performed by the same 
sonographer with a day-to-day coefficient of variation in FMD% of 11% and a 
coefficient of variation of 3% for baseline artery diameter which is deemed good-
excellent based on previous analysis (van Mil et al., 2016). 
     
Analysis was performed using custom designed edge-detection and wall-tracking 
software, which is largely independent of investigator bias. Previous articles contain 
detailed descriptions of this analytical approach (Woodman et al., 2001, Black et al., 
2008). Reproducibility of diameter measurements using this semi-automated software 
is significantly better than manual methods, significantly reduces observer error, and 
possesses within-day coefficient of variation of 6.7% (Woodman et al., 2001). 
Allometric scaling for baseline diameter was performed (Atkinson and Batterham, 
2013). FMD analysis was performed by a researcher blinded to the group allocation 
using a single blinded coding-randomised procedure.     
 
Ischaemia Reperfusion. Immediately following the baseline FMD, a temporary, 
endothelial IRI was induced by inflating a cuff around the upper arm to 220 mmHg 
for 20 min using a rapid inflation pneumatic device. This was followed by a 20 min 
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reperfusion period before the FMD protocol was repeated. A calculation of the 
relative % reduction in endothelial function following endothelial IRI was performed. 
The immediate decrease in FMD following temporary endothelial dysfunction 
induced by the 20 min cuff inflation is believed to reflect a reperfusion injury and 
reduced nitric oxide (NO) bioavailability (Loukogeorgakis et al., 2005, 
Loukogeorgakis et al., 2010, Aboo Bakkar et al., 2018).  The relative % decrease in 
FMD following IRI was calculated by dividing the absolute change between the two 
FMD’s by the baseline FMD *100.  
 
Cerebrovascular function (baseline velocity & dynamic cerebral autoregulation). 
Measurements of middle cerebral artery velocity (MCAv) and dynamic cerebral 




rIPC: The participants randomised into the rIPC intervention group (n=11) each 
received a hand held BP device (Welch Allyn DuraShockTM  DS45, New York, USA ) 
to self-administer rIPC. The cuff was placed around the upper arm and inflated to 220 
mmHg for five min, followed by five min deflation, and this cycle was repeated a 
further three times. This process was performed daily for seven days. The arm to which 
the participants applied the rIPC was randomised between the same arm the FMD’s 
were performed (IPC arm, n=5) and the contra lateral arm (n=6). Participants were 
supervised for their first rIPC bout to ensure it was correctly performed and were then 
free to perform the rIPC at any time of day and noted this in a diary to monitor 
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compliance.  Participants were instructed to follow their normal routine and to abstain 
from any new physical activity or changes in dietary habits 
 
Control: Each participant (n=10) was instructed to follow their normal routine and to 
abstain from any new physical activity or change in dietary habits.   
 
4.2.5 Statistical analysis 
 
Given that this is a pilot study to obtain estimates of primary and secondary outcome 
variables, no a priori sample size was calculated. The primary outcome in the study is 
FMD and the primary comparison is between pre to post intervention. Using the data 
collected (rIPC group n=11, control group n=10) in the study we calculated post hoc 
power of the present study, but also calculated the sample size for a future, fully 
powered randomised control trial for both primary and secondary outcome variables  
(G*Power 3.1.5).  
For exploratory purposes, we performed statistical analysis on the primary comparison 
(i.e. pre-to-post) to provide an estimate of the change in the primary and secondary 
outcome variables. Delta changes (∆) from pre to post were calculated for each group 
and entered as the dependent variable in a linear mixed model (Statistical Package for 
the Social Sciences, Version 20: SPSS Inc., Chicago, IL) with pre-intervention data 
used as a covariate. Data are presented in the text as mean and 95% confidence 
intervals (95%CI). P-values are presented, but not interpreted. The changes in the data 
are described in relation to a minimally clinical important difference (MCID) of 1% 
for FMD, calculated based upon previous intervention studies (Jones et al., 2014, 
Jones et al., 2015, Schreuder et al., 2015) and from a meta-analysis indicating that 1% 
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improvement in brachial FMD decreases the risk of future cardiovascular events by 
13% (Inaba et al., 2010). The MCID for LF gain was between 0.07 and 0.26%cm s-
1 %.mmHg-1mm Hg/%. This was based on studies showing differences between 
healthy and diseased populations (van Beek et al., 2012, Lewis et al., 2019) due to the 
limited intervention studies to date.  
4.3 Results 
 
Participants allocated to each intervention were similar in terms of age, BMI and BP 
status (Table 4.1). Participants randomised into the rIPC intervention group (N=11) 
demonstrated 96% compliance to the rIPC intervention. Data presented as absolute 
change following either intervention with statistical analysis comparing the 
differences between changes following rIPC or control (no rIPC).   
4.3.1 Cerebrovascular function 
 
Low frequency normalised gain changed by 0.23 %cm s-1 %.mmHg-1mm Hg/%  (-
0.12, 0.59; P=0.18) following rIPC compared to control from pre to post, which was 
greater than the lower level of the MCID of 0.07 and 0.26. The data provided 29% 
power to detect a between-group difference in LF normalised gain from pre-post.  
Using this data a sample size of 50 in each group would provide 90% power to detect 
a statistically significant (P<0.05) between group difference in LF normalised gain in 
a future randomised control trial.  
In the current study, the directional changes in any of the dCA variables were 
negligible between conditions (Table 4.4). The associated changes in MCAv, PetCO2 
or CbVC were negligible between both conditions and over time from pre to post and 
post 8 (Table 4.3). MAP decreased by 4 mmHg (2, 6 mmHg) across both interventions. 
78 
 
Similarly, SBP decreased by 5 mmHg (-9, -1 mmHg) and DBP by 3 mmHg (-5, -1 
mmHg). 
4.3.2 Brachial artery endothelial function 
 
Baseline FMD: Brachial artery FMD improved by 1.3% (95%CI: 0.69 to 3.80; P=0.09) 
with rIPC compared to control (no rIPC) from pre to post, with the change following 
the rIPC intervention being greater than the MCID of 1%. The data provided 65% 
power to detect a between-group difference in FMD from pre-post.  Using this data, a 
sample size of 20 in each group would provide 90% power to detect a statistically 
significant (P<0.05) between groups in FMD in a future randomised control trial.  
In the current study, FMD was 0.9 (-3.9, 2.0 %) lower in the rIPC group compared to 
control at pre, but 0.9 (-2.3, 4.0 %) higher than control at post, which remained higher 
at post+8 (0.8 (-2.3, 3.9 %), Figure 4.3). The associated changes in baseline diameter, 
peak diameter, shear rate or time-to-peak diameter between interventions or over time 
were negligible from pre to post and post 8 (Table 4.2). Within the rIPC condition, the 
limb to which the rIPC was administered was compared with the contralateral limb 
(interventions limb vs contralateral limb) and displayed no main effect of limb (P>0.05) 
confirming that the associated changes observed occurred as a result of both remote 
IPC and local IPC.     
Endothelial IRI: When examining the FMD after the endothelial IRI (Table 4.2). FMD 
was 2.3 (-5.4, 0.8%) lower in the rIPC group compared to control at pre, but only 0.1 
(-2.8, 2.6%) lower at post and 0.5 (-2.9, 2.0%;) at post+8. FMD increased over the 
intervention period by 0.7% (-0.1, 1.6). These directional changes were similar when 
the FMD data was expressed as a relative change. Prior to the intervention, the relative % 
decrease in FMD in response to IRI was 24.7% (-10.4, 49.7%) greater in the rIPC 
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group compared to control (Table 4.2). This difference was attenuated to 4.5% (-23.9, 
14.9%) at post and 1.4% (-22.5, 19.6%) at post+8.  
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Figure 4.3: Baseline Brachial artery FMD% (A), Post IR FMD% (B) and the relative % 
decrease (C) before (Pre), immediately after (Post) and eight days following the 
intervention (Post+8) in the rIPC group (closed circles) and control group (open 
circles).* Denotes significant main effect from time (P<0.05). Abbreviations; FMD, 









The aim of this study was to obtain estimates of changes in peripheral conduit artery 
endothelial and cerebrovascular function and the response to endothelial IRI to 7-days 
of daily limb rIPC in T2DM. Expanding on the study presented in chapter 3, this study 
not only examined the cerebrovascular function response to rIPC but also incorporated 
the peripheral vascular bed into the research design.  This study provides preliminary 
evidence that 7-days of daily rIPC in a representative sample of patients can enhance 
peripheral conduit artery endothelial function measured using FMD, and provide 
protection against a temporary decline in endothelial function following ischaemia 
reperfusion. Although the observations suggest that rIPC had little impact on 
cerebrovascular function, the preliminary directional findings and sample size 
estimations suggest the ability of a rIPC intervention to improve peripheral vasculature 
in T2DM. These effects should be explored further in a larger, fully powered trial.  
 
This present study provides preliminary evidence that daily rIPC can increase conduit 
artery endothelial function. This is clinically important given that individuals with 
T2DM exhibit endothelial dysfunction (Calles-Escandon and Cipolla, 2001, Tabit et 
al., 2010) and are also at high risk of microvascular disease of the small vessels. 
Chronic hyperglycaemia limits the ability of the endothelial cells to produce nitric 
oxide (NO) which has important anti-atherogenic properties, contributing to the 
maintenance of vascular homeostasis (Sena et al., 2013). This is relevant as vascular 
dysfunction plays a major role in the development of cardiovascular complications 
(Luscher et al., 2003). Given that a meta-analysis confirmed that a 1% improvement 
in brachial FMD decreases the risk of future cardiovascular events by 13% (Inaba et 
al., 2010), strategies to improve vascular endothelial function are crucial. Numerous 
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clinical outcome studies have demonstrated that brachial artery FMD is a good 
predictor of cardiovascular risk (Cohn et al., 2004). Improvements in FMD are 
associated with enhanced NO production (Green et al., 2014a) and NO pathways are 
impaired with diabetes (Williams et al., 1996, Avogaro et al., 2011). The data suggests 
that vascular endothelial function can be improved in 7 days and remain elevated 8 
days following the end of the intervention. Given that rIPC was administered in the 
arm that received the preconditioning stimulus as well as in the contralateral arm the 
data supports the notion that rIPC has local and systemic effects on the vascular system 
(Jones et al., 2014). As this present study was not designed as a mechanistic study, it 
is possible to only speculate on potential mechanisms involved in the change in FMD 
observed.  Episodic increases in shear stress is likely to represent a major physiological 
stimulus for the local improvements in FMD (Thijssen et al., 2016a) however is 
unlikely to have effected contralateral arm FMD. The mechanisms mediating the 
systemic effects of rIPC remains elusive.  Systemic stimuli or circulating markers 
activated by rIPC more likely explain the remote improvement in conduit artery FMD. 
For example, rIPC leads to an increase in vascular endothelial growth factor and 
endothelial progenitor cells (Kimura et al., 2007), which may improve endothelial 
function in remote areas (Hill et al., 2003). However, more research studies are 
required to gain insight into exact mediating mechanisms.    
 
The present study provides evidence that daily rIPC can provide protection against 
endothelial IRI in T2DM. The endothelial IRI model performed in this study has been 
used by previous studies (Kharbanda et al., 2001, Luca et al., 2013) and is 
acknowledged as a surrogate model for myocardial reperfusion injuries. A similar 
model using forearm IRI identified that the decrease in FMD occurs as a result of a 
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decrease in plasma nitrite and plasma nitrate concentrations, indicating a reduction in 
NO bioavailability which is still decreased up to 50 min post reperfusion (Aboo 
Bakkar et al., 2018).  The findings in this study agree with previous rIPC studies 
showing (partial) prevention of endothelial dysfunction after IRI when preceded by a 
bout of rIPC (Luca et al., 2013). Reduced endothelial dysfunction against IRI is of 
clinical significance given that patients with T2DM demonstrate more extensive injury 
in response to ischaemia reperfusion (Russo et al., 2017). Interestingly, a previous six-
week rIPC intervention performed on patients with T2DM with foot ulcers identified 
an augmentation in the wound size of the foot ulcers in the patients who received the 
rIPC compared to a control (Shaked et al., 2015), further demonstrating the capability 
of a rIPC intervention to treat ischaemic induced complications in a diabetic patient 
group.  
 
This study identified that a 7-day repeated rIPC intervention had little impact on 
resting MCAv or dCA. Despite the considerable literature on the effects of rIPC on 
cardiac and peripheral vascular function in humans, there are few studies on 
cerebrovascular function, even with stroke and cerebrovascular disease being a 
leading cause of death worldwide (Roger et al., 2012). Post-hoc analysis of power was 
performed which revealed that more participants would have been required for 
adequate statistical power; therefore the data should be interpreted with caution. It is 
likely that control of cerebral autoregulation is multifactorial encompassing 
neurogenic, metabolic, myogenic and endothelial factors (Tzeng and Ainslie, 2014). 
The exact contribution of each, including the endothelium is debated. Evidence 
suggests that the endothelium carries mechanoreceptor properties that allows it to 
actively contribute to cerebral autoregulation following changes in arterial shear stress 
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and transmural pressure (Peterson et al., 2011). Therefore, a healthier and more active 
endothelium may have translated to improved dCA, yet this was not evident in the 
present study. Given that dCA is controlled by highly sensitive and tight regulatory 
factors, it is possible that 7 days of rIPC was not a sufficient enough stimulus to result 
in any change/adaptation. This potential explanation is supported by the fact that the 
only previous studies examining repeated rIPC on human cerebrovascular markers 
employed daily rIPC for 300 days (Meng et al., 2012), 180 days (Meng et al., 2015) 
and 365 days (Wang et al., 2017) identifying increases in cerebral perfusion and 
reductions in stroke reoccurrence but did not assess functional markers of the cerebral 
circulation. Whilst there is also a strong association between T2DM and 
cerebrovascular dysfunction (Zhou et al., 2014), none of the participants in this study 
had any previous documented cerebrovascular complications unlike the 
aforementioned studies and were of shorter duration of T2DM.  
Given the data was collected for the purposed of generating estimates for a larger trial 
it is important to acknowledge the small sample and limited statistical power. It is also 
important to acknowledge a number of other study limitations. Pre-intervention 
characteristics, primarily MAP, metformin and statin use were different between the 
intervention and control group and some evidence now suggests that certain 
medication used to treat risk factors of cardiovascular disease can alter the response to 
cardio protective interventions (Ferdinandy et al., 2014). Additionally, HbA1c data 
was not collected to examine clinical relevance to glucose control nor biomarkers of 
NO bioavailability. Stratification for medication and markers of glucose control and 
NO bioavailability should be incorporated into a larger fully powered future trial.	
Lastly, MCAv was measured using transcranial Doppler, a technique that provides a 
reliable surrogate for absolute cerebral blood flow providing the insonated artery 
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diameter remains constant across and between the study conditions (Ainslie and 
Hoiland, 2014). A future trial may consider assessment of extra cranial vessels (e.g. 
internal carotid artery) with ultrasound to assess changes in artery diameter as an 
indicator of changes in diameter.   
4.5 Conclusion 
 
The present study has provided estimates of sample size for a randomised control trial 
exploring the impact of daily rIPC for 7 days on peripheral endothelial and 
cerebrovascular function. The directional changes outlined from this pilot study 
suggest peripheral endothelial function and responses to endothelial IRI can be 
enhanced by daily rIPC in patients with T2DM and should be investigated in a fully 
powered randomised control trial. In contrast to peripheral arteries, no changes were 
evident in the cerebrovasculature as no change was found in MCAv or in dCA. Taken 
together, our results on the impact of repeated rIPC on cardio- and cerebrovascular 



















Chapter 5: The impact of 
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5.1 Introduction  
 
Repeated rIPC interventions can improve cardiovascular parameters and clinical 
endpoints in healthy individuals and those with CVD risk factors respectively. For 
example, repeated rIPC interventions ranging from 1 to 8 weeks have mediated 
improvements in vascular endothelial function in both healthy (Jones et al., 2014, 
Jones et al., 2015) and T2DM (see Chapter 4), increases in coronary flow reserve in 
heart failure patients (Kono et al., 2014), increased presence of endothelial progenitor 
cells (Liang et al., 2015) and reduced diabetic foot ulcer wound size (Shaked et al., 
2015). Collectively, suggesting that repeated rIPC interventions could be useful in 
preventing and reducing cardiovascular events and complications.  
There is emerging evidence that repeated rIPC interventions can also have beneficial 
effects on the cerebrovasculature. A small number of studies have shown repeated 
rIPC can increase CBF in stroke patients and reduce the rate of stroke reoccurrence 
(Meng et al., 2012, Meng et al., 2015, Mi et al., 2016, Wang et al., 2017). Nevertheless, 
Chapter 3 in this thesis attempted to understand how rIPC exerts its effects of the 
cerebrovasculature, demonstrating that a single bout of rIPC has negligible impact on 
CBFv or dCA as a marker of cerebrovascular function. Chapter 4 provided some 
evidence that 7-day daily repeated rIPC intervention in individuals with T2DM did 
not change cerebrovascular function. A number of important methodological 
differences are evident between experimental studies contained in this thesis (see 
Chapters 3 & 4) and the previous studies showing benefits on cerebrovascular health 
(Meng et al., 2012, Meng et al., 2015, Mi et al., 2016, Wang et al., 2017). Key 
differences relate to participant population, length of rIPC intervention and 
measurement techniques. The length of the intervention and the number of rIPC bouts 
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performed over the intervention, which collectively can be termed the dose of rIPC, is 
an important aspect to consider. It is possible that a larger dose (in both duration and 
frequency) of rIPC might have a greater effect on cerebrovascular function. 
An alternative approach to increase the rIPC stimulus is to combine the repeated rIPC 
with exercise training. Regular exercise bouts may potentially provide an additional, 
but not mutually exclusive, preconditioning stimulus for the vascular system thus 
combining rIPC with exercise may increase the beneficial adaptations observed with 
rIPC alone. The mechanisms responsible for the beneficial effects of repeated rIPC 
versus exercise training may differ. Where effects of rIPC may relate to both neural 
and humoral pathways (Anttila et al., 2016), benefits of exercise (preconditioning) 
may relate to repeated systemic elevations in shear stress (Hambrecht et al., 2003, 
Tinken et al., 2010, Thijssen et al., 2016a). It has not yet been investigated whether 
adding exercise to the rIPC stimulus leads to a larger adaptation in peripheral and/or 
any adaptation in the cerebral vasculature at all. 
Therefore, the primary aim of this study was to examine whether exercise training 
could enhance the effects of repeated rIPC on cerebrovascular and peripheral conduit 
artery function more than repeated rIPC alone in individuals with increased risk of 
CVD. It was hypothesised that (i) exercise training would provide additional stimulus 
to elicit greater improvements in both cerebo- and peripheral vascular function 








5.2.1 Participants  
 
Nineteen participants with increased risk of cardiovascular disease were recruited 
(Figure 5.1). Participants were recruited on the criteria of; body mass index (BMI) >30 
kg/m2 or waist circumference ≥94cm (male), ≥80cm (female) as well as either raised 
blood pressure (>130 /85 mmHg) or diagnosed with hypercholesterolemia (Table 5.1). 
Individuals were excluded if they had a history of stroke (including TIAs), myocardial 
infarction, thrombosis, congenital heart disease, type 1 diabetes or currently smoking. 
Participants were informed of the study protocol verbally and in writing before 
providing written informed consent. The study was approved by the local ethics 
committee (approval number 17/SPS/056) and conformed to standards set out by the 






















Figure 5.1: Screening, recruitment, retention and completion of the study.  
 
5.2.2 Research Design  
 
Participants underwent two initial visits to the laboratory. Following an overnight fast 
and refraining from alcohol and exercise for 24hr and caffeine for 12hr, visit 1 
consisted of anthropometric measurements, fasting blood glucose, assessment of 
cerebrovascular function and assessment of brachial artery endothelium function 
before and after a temporary ischaemia reperfusion injury (IRI). Visit 2 consisted of a 
cardio-respiratory fitness test (VO2peak). Both visits were conducted within four days 
of each other and all completed in a temperature-controlled laboratory (23±1°C). 
Participants were then randomly allocated into the rIPC + Exercise group (3 x rIPC 
and 3 x 50min exercise per week) or rIPC group (3 x rIPC per week). Randomisation 
was performed following the first testing visit using a computer-generated-sequences 
94 
 
to avoid bias. All measurements performed in Visit 1 were repeated following the end 
of the 8-week intervention. Measurements from Visit 2 were repeated again following 
the completion of the 8 weeks. All post intervention measurements were performed 
within 7 days of last exercise or rIPC bout.  
5.2.3 Measurements 
 
Cerebrovascular function: Measurement of baseline CBFv, dCA  and CVR were 
completed as per the information in Chapter r3, section 4.2.3. 
Brachial artery endothelium-dependent vasodilation: FMD was performed on the left 
of arm of each participant before and after an IR injury as per the information in 
Chapter 4, section 4.2.3 and performed by the same sonographer throughout the entire 
thesis. 
 
Maximal oxygen uptake: The cardio-respiratory fitness test (VO2peak) was performed 
on a treadmill (H/P Cosmos, Pulsar 4.0, Nussdorf-Traunstein, Germany) in order to 
quantify peak aerobic capacity. A modified version of the Bruce et al. (1973) protocol 
was adopted as this is frequently used protocol in sedentary/high risk populations 
(Pugh et al., 2013, Sprung et al., 2013). Following a 5-minute warm-up period at a 
self-selected speed, the protocol begins with a 2-minute stage at 2.2km/h on a flat 
gradient, followed by 2 minutes at 2.7km/h at a 5% gradient. Subsequently, stepwise 
increments in speed and gradient are applied evert minute until volitional exhaustion. 
Breath-by-breath expired gases were continuously monitored (Oxycon Pro, Jaeger, 
Hochberg Germany) for oxygen consumption (ml/kg/min) and were averaged over 15 
seconds. Peak oxygen uptake was calculated from the highest consecutive 15-second 
period of expired gas fractions. Heart rate was measured continuously using short-
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range telemetry (RS800, Polar, Finland) alongside subjective effort (RPE) using the 
6-20 Borg scale. All participants reached the criteria for volitional exhaustion based 
upon heart rate, Borg scale and respiratory exchange ratio (Edvardsen et al., 2014).     
 
Fasting blood glucose: Blood samples were obtained from the antecubital vein via 
standard venepuncture technique (Vacutainers Systems, Becton-Dickinson). All 
samples were collected into vacutainers containing a polymer gel for serum separation. 
Centrifugation for 10 minutes at 1000g at 4℃ was applied and samples were stored at 
-80℃ for subsequent analysis. Plasma glucose was determined spectrophotometrically 
using commercially available kits (Randox Laboratories, Antrim, UK) with each 
sample analysed in duplicate.    
 
5.2.4 Interventions  
 
Remote Ischaemic Preconditioning           
All participants in both groups performed three bouts of rIPC per week for 8 weeks. 
A single bout of rIPC consisted of a pressure cuff (Welch Allyn DuraShockTM  DS45, 
New York, USA) inflated around the upper arm (220mmHg) for five minutes preceded 
by five minutes of reperfusion, repeated four times (total time 40 minutes). The arm 
in which the rIPC was applied to was randomised and participants were free to perform 
the rIPC bouts freely and not follow a pre-set routine. All participants were provided 
with an intervention diary in order to increase compliance.       
Exercise intervention 
Those randomly assigned to the rIPC+Exercise group performed three 50 minute 
exercise sessions per week for 8 weeks (98% compliance). All sessions were 
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performed on a cycle ergometer (Wattbike Trainer, Wattbike Limited, country) in a 
temperature controlled laboratory (18±2°C). The intensity of the exercise sessions was 
set to 70% maximum heart rate (HRmax) and all sessions were supervised in order to 
ensure target HR was achieved and maintained throughout the session.  
5.2.5 Statistical analysis  
 
Analysis was performed using Statistical Package for Social Sciences (Version 26; 
SPSS Inc., Chicago, IL). Baseline characteristics between conditions (Table 5.1) was 
analysed using an independent samples t-test. All other data were analysed using a 
linear mixed model, with delta changes (∆) from week 0-week 8 calculated and added 
to the model as a dependent variable and pre-intervention data entered as a covariate. 
Linear mixed model (LMM) P values in results represent difference in the absolute 
change following each intervention.  Statistical significance was delimited at P < 0.05 
and exact P values are cited (P values of ‘0.000’ provided by the statistics package are 
reported as <0.001). Significant interactions and main effects were followed up using 
LSD pairwise comparisons. Data are presented as mean and 95% confidence intervals.    
5.3 Results  
  
5.3.1 Resting hemodynamic  
 
The directional changes in MAP (P=0.45), MCAv (P=0.30) and PCAv (P=0.56) were 













(4 females & 
6 males) 
rIPC only  
(2 females & 7 
males) 
P value 
Age (years) 52 ± 8 51 ± 12 0.87 
Height (m) 1.7 ± 0.1 1.7 ± 0.1 0.26 
Weight (kg) 97.8 ± 21.5 108.2 ± 21.7 0.31 
Body mass index 
(kg/m2) 
34 ± 5 35 ± 5 0.56 
Waist circumference 
(cm)  
107 ± 17 109 ± 13 0.75 
Resting heart rate 
(bpm) 
69 ± 8 69 ± 6 0.96 
Systolic blood 
pressure (mmHg) 
137 ± 15 139 ± 12 0.75 
Diastolic blood 
pressure (mmHg) 
80 ± 13 84 ± 6 0.42 
Mean arterial blood 
pressure (mmHg) 
99 ± 12 102 ± 5 0.50 
Fasting blood glucose 
(mmol/L)  
5.9 ± 0.7 6.0 ± 0.7 0.70 
Medications  
Statins  3 (30%) 3 (33%)  
β-blockers 1 (10%) 1 (11%)  
Calcium channel 
blockers 
1 (10%) 0 (0%)  
alpha-1 adrenergic 
blockers 




3 (30%) 2(22%)  
Biguanides 2 (20%) 2 (22%)  
 








Table 5.2: Baseline hemodynamic, cardiorespiratory fitness and fasting blood 
glucose data from before (week 0) and after (week 8) each intervention. 
 
 rIPC + Exercise rIPC only LMM 
Week 0 Week 8 Week 0 Week 8 Condition 
MCAv (cm.s-
1) 
56±10 57±9 54±14 53±12 0.30 
PCAv (cm.s-
1) 
37±3 36±4 36±3 36±2 0.83 
PetCO2 
(mmHg) 
38.5±3.1 38.0±3.7 41.6±2.7 39.6±3.5 0.35 
MAP 
(mmHg) 
99±13 95±11 102±7 99±5 0.45 
Resting HR 
(bpm) 
69±9 68±11 69±6 70±8 0.61 
VO2peak 
(ml/kg/min) 









77±27 89±25 n/a n/a <0.001 
 
Data presented as means ± SD. Abbreviations; MCAv, middle cerebral artery velocity; 
PCAv, posterior cerebral artery velocity; PetCO2, partial pressure of end tidal carbon 
dioxide; MAP, mean arterial pressure; HR, heart rate; rIPC, remote ischaemic 
preconditioning; LMM, linear mixed model.  
 
5.3.2 Cerebrovascular function 
 
Parameters of spontaneous (Table 5.3) and dynamic (Table 5.4) cerebral 
autoregulation changed similarly with both interventions (P>0.05).  Pararmeters of 
cerebral reactivity including CVRCO2, CbVCiCo2 or MAP reactivityCo2 changed 




Table 5.3: Power spectral and transfer function analysis of dynamic cerebral 
autoregulation during spontaneous changes in BP and CBFv. 
 
 rIPC + Exercise rIPC only LMM 
 Week 0 Week 8 Week 0 Week 8  
Power Spectrum 
Baseline MCAv power  (cm/s2) 
VLF 2.69±1.17 2.86±1.53 2.41±2.15 2.87±1.37 0.13 
LF 1.69±0.96 1.81±1.30 1.58±0.122 2.61±.1.86 0.84 
HF 0.47±0.24 0.52±0.28 0.81±0.27 0.97±0.21 0.19 
Baseline BP power (mmHg2) 
VLF 4.23±1.47 3.43±1.95 4.52±2.72 4.96±3.62 0.21 
LF 2.26±1.43 2.28±2.00 2.05±1.17 1.77±0.86 0.32 
HF 0.44±0.13 0.40±0.22 0.44±0.31 0.43±0.23 0.69 




0.68±0.23 0.73±0.32 0.51±0.08 0.51±0.06 0.72 
VLF Ngain 
(%.mmHg-1) 
1.15±0.22 1.34±0.62 0.98±0.25 1.35±0.75 0.69 
VLF phase 
(radians) 
0.77±0.32 0.87±0.41 1.03±0.48 1.08±0.69 0.98 
VLF 
coherence 
0.54±0.14 0.51±0.01 0.52±0.23 0.50±0.20 0.14 
LF gain 0.74±0.29 0.75±0.29 0.75±0.25 0.88±0.34 0.16 
LF Ngain 1.26±0.41 1.40±0.41 1.35±0.45 1.43±0.59 0.54 
LF phase 0.52±0.38 0.65±0.31 0.89±0.49 0.74±0.41 0.31 
LF coherence 0.56±0.09 0.55±0.12 0.50±0.11 0.51±0.21 0.31 
HF gain 1.00±0.43 0.99±0.50 0.97±0.53 1.00±0.31 0.20 
HF Ngain 1.77±0.42 1.81±0.70 1.47±0.32 1.84±0.45 0.43 
HF phase 0.14±0.66 0.09±0.51 0.33±0.21 0.18±0.08 0.30 
HF coherence 0.61±0.08 0.63±0.08 0.63±0.06 0.63±0.07 0.75 
.  
Data presented as means ± SD. Abbreviations; PS, power spectrum; VLF, very low 
frequency; LF, low frequency; HF, high frequency; MCAv, middle artery cerebral 







Table 5.4: Power spectrum densities of forced oscillations in mean arterial pressure 
and cerebral blood flow velocity during squat-stand manoeuvres.   



































0.42±0.19 0.49±0.17 0.46±0.18 0.52 
Coherence 0.72±0.0
7 
0.72±0.08 0.72±0.04 0.71±0.08 0.91 
 
Data presented as means ± SD. Abbreviations; rIPC, remote ischaemic 
preconditioning;; BP, blood pressure; MCAv, middle cerebral artery velocity; Ngain, 













Table 5.5: Cerebrovascular reactivity to 5% carbon dioxide 
 rIPC + Exercise rIPC only LMM 
Week 0 Week 8 Week 0 Week 8 Condition 
























0.5±0.4 0.9±0.6 1.1±0.7 1.5±0.7 0.37 
 
Data presented as means ± SD. Abbreviations; MCAv, middle cerebral artery velocity; 
CvVCi, cerebrovascular conductance index; MAP reactivity, mean arterial pressure; 
rIPC, remote ischaemic preconditioning;  LMM, linear mixed model. 
 
 
5.3.3 Brachial artery endothelium-dependent vasodilation 
 
Brachial artery FMD% increased by 1.6% (95%CI;0.4, 2.8) in the rIPC+Ex 
intervention and by 0.3% (-1.1, 1.5) in rIPC only intervention but there was no main 
effect of condition (P=0.65, Figure 5.2). No intervention-mediated differences were 
evident in baseline diameter, peak diameter, SRAUC or time to peak (P>0.05, Table 
5.6).       
 
The directional changes in brachial artery FMD following an IR injury after both 
interventions were similar (P=0.50).  FMD reduced by of 0.5% (-2.2, 1.3) following 
rIPC + Ex and by 0.2% (-1.7, 1.6) following the rIPC only. No intervention-mediated 
differences were evident in baseline diamter, peak diameter, SRAUC or time to peak 
(P>0.05, Table 5.6).   
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5.3.4 Cardiorespiratory fitness 
 
VO2peak increased by 2.8 ml/kg/min (1.7, 3.9) following the rIPC + Ex intervention 
and increased by 0.1 ml/kg/min (-1.0, 1.4) following the rIPC only intervention there 
was no main effect of condition (P=0.69). 
5.3.5 Blood glucose 
 
There was no main effect of condition between rIPC + Ex and rIPC only in changes 







                 Figure 5.2: Individual data points w
ith m
eans±SD












Table 5.6: Brachial artery characteristics before and after an ischemia reperfusion 
injury    
 
Data presented as means ± SD. Abbreviations; FMD, flow mediated dilation; AUC, 
area under the curve: LMM, linear mixed model   
 
 
 rIPC + Exercise rIPC only LMM 
Week 0 Week 8 Week 0 Week 8 Condition 
Baseline       
Resting diameter 
(mm) 
4.0±0.9 4.1±1.0 4.2±0.7 4.1±0.8 0.40 
FMD% 6.5±3.2 8.1±3.2 6.1±1.2 6.4±1.6 0.65 
Scaled FMD% 6.5±2.6 7.9±1.3 6.1±2.4 6.3±2.3 0.35 
Time to peak (sec) 77±32 67±29 72±24 63±26 0.83 







Post Ischemia Reperfusion Injury 
Resting diameter 
(mm) 
4.4±1.0 4.4±1.0 4.3±0.7 4.6±0.9 0.95 
FMD% 1.9±3.3 1.4±4.1 1.0±2.5 0.8±1.2 0.50 
Scaled FMD% 1.9±2.9 1.3±3.7 1.0±3.0 1.0±3.0 0.56 
Time to peak (sec) 79±35 73±32 63±39 62±33 0.87 







The present study aimed to examine whether combining aerobic exercise training with 
rIPC resulted in greater improvements in the cerebral and peripheral vasculature 
compared to repeated rIPC alone in individuals with increased risk of CVD. The 
results of this study suggest that increasing the preconditioning stimulus by combining 
rIPC intervention with exercise training does not mediate greater changes in the 
cerebral or peripheral vasculature when compared directly to rIPC alone.  
 
Despite increasing the dose of rIPC (compared to previous 7-day rIPC study, see 
Chapter 4) and increasing the rIPC stimulus (by adding exercise training) negligible 
changes were observed in markers of cerebrovascular function, including CBFv 
following both interventions. Studies that examined repeated rIPC and found increases 
in CBF and CBFv typically adopted longer interventions and in patient groups with 
overt cerebrovascular disease (Meng et al., 2012, Meng et al., 2015, Mi et al., 2016, 
Wang et al., 2017). Nevertheless, the aforementioned studies had not examined 
cerebrovascular function to understand how the positive changes in CBF and risk of 
stroke occurrence. The markers of cerebrovascular function dCA and CVR are 
recognised as independent predictors of ischaemic stroke (Markus and Cullinane, 
2001) and provide in-depth information about mechanoreceptor and chemoreceptor, 
control respectively (Rubanyi et al., 1990, Hoiland et al., 2019). Given the impact of 
repeated rIPC in stroke patients, it was hypothesised that the repeated rIPC 
intervention in the present study would mediate positive effects on the cerebral 
vasculature. Moreover, it was expected the addition of exercise would mediate a 
greater response, given that some previous exercise training studies have shown 
improvement in CVR and CBFv with exercise training interventions in a number of 
106 
 
ages and disease groups (Zhu et al., 2011, Akazawa et al., 2012, Murrell et al., 2013). 
Whilst it cannot be discounted that a longer intervention may have mediated positive 
changes, or that rIPC and exercise might have had an impact on cerebrovascular 
function in individuals with overt disease, the data in the present study suggest that 
repeated rIPC intervention has negligible impact on cerebrovascular function. Within 
this present study, further investigations into dCA were performed through assessing 
cerebral autoregulation during both spontaneous and driven BP oscillations, whereas 
the studies presented in chapter 3 and 4 focus primarily on driven BP oscillations. By 
extending the scope of the investigation into multiple different methods of assessing 
dCA, this allows us to identify if similar response are observed in both spontaneous 
and driven oscillations. Indeed, it is currently debated as to which is the ‘best’ method 
of dCA assessment using TCD and TFA (Simpson and Claassen, 2018, Tzeng and 
Panerai, 2018). In this present study, and in a number of recent studies (Labrecque et 
al., 2017, Labrecque et al., 2019a), a multifactorial approach to the assessment of dCA 
was utilised in order to account for potential mechanistic differences in cerebral 
autoregulation from spontaneous or driven BP oscillations.       
 
The data from this study also shows that combining exercise training with rIPC 
mediates a 1.6% increase in FMD. Given that a 1% increase in FMD is indicative of a 
8-13% reduced risk of cardiovascular events (Thijssen et al., 2019b), the increase 
observed following the rIPC combined with exercise in the current study is of clinical 
importance. Intriguingly, a 0.3% increase in FMD was observed in the rIPC only 
group. This is somewhat smaller than a previous study employing the same repeated 
rIPC intervention in young healthy individuals (Jones et al., 2015). The differences in 
responses to the repeated rIPC intervention between the two studies may be explained 
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by differences in participant groups. Indeed, there is evidence to suggest differences 
in the time course of changes in FMD are apparent depending on health status 
following exercise interventions (Schreuder et al., 2015). Similarly, an acute bout of 
rIPC has attenuated efficacy in older and diseased individuals in response to FMD 
following an endothelial reperfusion injury (van den Munckhof et al., 2013, Seeger et 
al., 2016). Collectively, the data presented in this study suggests that either; (i) rIPC, 
with or without exercise is unable to evoke improvements in cerebral vascular function 
or, (ii) individuals at risk of CVD may require large ‘doses’ of rIPC and exercise in 
order to mediate improvements compared to a healthier population. Additionally, the 
0.3% increase in FMD% following the rIPC only intervention is also surprising given 
the data presented in chapter 4 showed a 1.3% increase in FMD% following 7 days of 
daily rIPC. Collectively, this evidence suggests that the intensity and frequency in 
which the rIPC is applied may alter the effectiveness of the outcome measurements, 
rather than it being attributed to the ‘dose’ of the rIPC. Such differences in results 
outlines the importance of future studies identifying an optimal ‘dose’ of rIPC in order 
to maximise adaptations as to date, no such study has been published. 
 
Interestingly, no protective effect from either intervention on post IR injury FMD was 
observed. Numerous studies have acknowledged that rIPC provides protection against 
the IR injury model adopted in the current study by means of attenuated differences 
between pre and post IR injury FMD’s (Luca et al., 2013, van den Munckhof et al., 
2013) (see Chapter 4). This inconsistent finding may be attributed to rIPC intervention 
intensity, given that those aforementioned studies applied either acute (one bout) or 
daily rIPC in the lead up to the IR injury, building a more substantial preconditioning 
effect. Additionally, and again some-what surprising was the inability of the exercise 
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to elicit any protection, especially given the suggestion that exercise does pose a 
preconditioning-like effect (Thijssen et al., 2018). Both lifelong exercise (Maessen et 
al., 2017) and short-term exercise interventions (Thijssen et al., 2019a) have resulted 
in increased tolerance to endothelial IR injury. Given a clinically important change in 
fitness was observed in the rIPC combined with exercise intervention, it might be more 
plausible that exercise type may represent an explanation for differences in post IR 
injury results. However, Thijssen et al found that the protective effects were present 
and not different following moderate and high intensity exercise (Thijssen et al., 
2019a). Assessing further vascular parameters may provide additional information in 
understanding the effects of an IR injury, with some studies measuring low flow 
mediated constriction in order to explore a different mechanistic view (Rakobowchuk 
et al., 2013, Carter et al., 2014b). Alternatively, methodological differences may 
explain differences in post IR injury FMD results, with the present study adopting a 
15 minute- ischemia-15 minute-reperfusion model whereas Thijssen et al. (2019a) 
used 5 minutes of ischaemic handgrip exercise followed by 15 minutes reperfusion. 
Further research is warranted to understand the potential preconditioning effect of 




In conclusion, combining 8 weeks of rIPC with exercise does not result in greater 
changes in cerebrovascular function and peripheral endothelial function compared to 
a rIPC only intervention in individuals at increased risk of CVD. Therefore, based on 
this data, careful consideration and further investigation is recommended exloring 
whether rIPC offers a beneficial short-term intervention for improvement of systemic 






Chapter 6: Dynamic cerebral 
autoregulation assessed using 
squat stand manoeuvres and 
transfer function analysis is not 
influenced by age, sex, 
cardiovascular disease risk 














Cardiovascular and cerebrovascular disease is the leading cause of morbidity and 
mortality worldwide (Townsend et al., 2016). The age related decline is CBF is well 
established (Ainslie et al., 2008b, Tarumi and Zhang, 2018), but the age related 
changes in cerebrovascular function and haemodynamic responses contributing to 
CBF regulation are not well described.  The delivery of oxygenated blood to the brain 
over a wide range of systemic BP levels by neurogenic, myogenic and endothelial 
factors is essential in order to maintain normal brain functioning (Tzeng and Ainslie, 
2014). dCA refers to the intrinsic ability of the brain to maintain adequate CBF in the 
presence of transient changes in arterial BP that occur over a number of seconds 
(Aaslid et al., 1989). dCA acts as a defensive mechanism protecting the brain from 
potential damage as a result of high or low BP (van Beek et al., 2008). At the same 
time, BP is controlled neurally by the baroreflex (Monahan, 2007). Both of these 
regulatory systems are essential in maintaining stable CBF. Impairment in either of 
these regulatory mechanisms are early markers of cerebrovascular dysfunction and 
thus associated with increased the risk of cognitive impairment, dementia and stroke 
(Jordan and Powers, 2012, Laosiripisan et al., 2015). 
Over the past few years, it has been established in the literature that currently, the best 
way to assess dCA is to employ forced BP oscillations by performing repeated squat-
stand manoeuvres (Claassen et al., 2009b; Smirl et al., 2015; Simpson & Claassen, 
2018) and analyse the data using transfer function analysis (TFA) thus adhering to 
international recommended guidelines (Claassen et al., 2016). Following the 
guidelines studies found that, despite the age-related decline in CBF and increase in 
BP (Ainslie et al., 2008b), there is little evidence of impairment in dCA between young 
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and old (mean age 23 vs 66 years) healthy individuals (Smirl et al., 2015) or within 
clinical populations (e.g. Alzheimer’s) (Claassen et al., 2009a, Smirl et al., 2014a, 
Lewis et al., 2019) Chapter 3). There is some evidence of sex differences for efficiency 
of dCA but the directions of effect conflict (Xing et al., 2017, Favre and Serrador, 
2019, Labrecque et al., 2019a).  
In the largest such study to date, Xing et al. (2017) conducted a study (n=136) in 
healthy individuals aged 21 to 80 years to characterise the age and sex alterations in 
dCA. They reported dCA was not different across the lifespan but suggested women 
had a better dCA phase compared to men using 0.05Hz squat stand manoeuvres. 
Nevertheless, subsequent studies have suggested that cardiorespiratory fitness is an 
important factor when assessing sex differences in dCA (Labrecque et al., 2017, 
Labrecque et al., 2019a, Labrecque et al., 2019b). Moreover, Xing et al. (2017) also 
explored age and sex differences in cardiac baroreflex sensitivity (BRS) (quantified 
using BP and R-R intervals throughout the same squat-stand protocol). BRS was 
reduced in the older group but no sex differences were observed. BRS was positively 
correlated with dCA in young but not middle aged or older healthy participants. 
However, the fundamental relationship between dCA and cardiac BRS is unclear as 
other evidence suggests an inverse relationship in young healthy individuals 
participants (Tzeng et al., 2010), and no relationship in older endurance trained 
athletes (Aengevaeren et al., 2013) or in heart transplant recipients (Smirl et al., 2014a). 
The aim of the current study was 2 fold in order to build upon previous work (Xing et 
al., 2017); (i) to examine the impact of sex, cardiorespiratory fitness and the presence 
of CVD risk factors on dCA and cardiac BRS over the life span; and (ii) to explore the 
relationships between cardiac BRS and dCA whilst controlling for age and sex. By 
expanding upon the work by Xing et al., (2017) by incorporating individuals with 
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CVD risk factors and quantifying cardio-respiratory fitness, this will allow us to 
present findings from a demographically varied population. 
   
6.2 Methods 
 
6.2.1 Participants  
 
Data from eleven studies collected at Liverpool John Moores University, Research 
Institute for Sport and Exercise Science were examined for eligibility. Data were 
included if: (i) all measurements were performed with strict adherence to cerebral 
autoregulation network (CARNET) guidelines (Claassen et al., 2016), (ii), data for 
individual participants was provided (minimum; age, sex, BMI and resting BP), (iii) 
data was collected in studies that adhered to the Declaration of Helsinki. Of the data 
included, 146  participants are from four previously published studies (Carter et al., 
2018, Maxwell et al., 2019, Brislane et al., 2020, Carter et al., 2020) 
dCA and cardiac BRS recordings were complied with corresponding participant 
characteristics and medical history (where available) from eleven studies. When 
studies adopted a repeated measurements design, only baseline data were included. 
Participant data was excluded if the duration of recordings was < 5 minutes, and if the 
coherence value was < 0.4. Based on these criteria, 206 participants were with 83 
males and 123 females aged between 18-70 years.  All participants were non-smokers, 
with no previous myocardial infarction, stroke or thrombosis. Individuals clinically 
diagnosed with T2DM were treated with Metformin (n=18) or diet (n=8) at the time 
of data collection. Additional medications taken by participants included anti-
hypertensive (n=15) and lipid lowering (n=16) medication. Participants that had a 
113 
 
body mass index (BMI) >30kg/m2, diagnosed with hypercholesterolemia or type 2 
diabetes, as well treated or untreated ≥ stage 1 hypertension were stratified to a CVD 
risk group.  In total 45 of the individuals who were included with this study met the 
criteria for increased risk of CVD.  Out of the 123 females included within the study 
58 were post-menopausal. Post-menopausal women were classified based on having 
no menstrual cycle for at least 12 consecutive months and were not previously or 
currently taking any form of hormone therapy (Moreau et al., 2012).  
6.2.2 Measurements 
 
dCA: MCAv was measured using TCD, continuous blood pressure was monitored 
using Finapres and PetCO2 was recorded using a calibrated gas analyser throughout 
0.10 Hz squat stand manoeuvres to quantify dCA, as described in detail in Chapter 3.   
Baroreflex Sensitivity: Using the same 5-minute recording window during the 0.10 Hz 
squats-stand manoeuvres, continuous cardiac BRS was assessed. The cardiac BRS was 
determined by applying TFA to systolic BP (SBP) and R-R interval (pressure-cardiac 
interval) at the point frequency (low frequency) of the squat-stand manoeuvres (0.10 
Hz). Data analysis was performed using a commercially available software Ensemble 
(Version 1.0.0.28, Elucimed, Wellington, New Zealand). Mean gain (magnitude of 
relationship between SBP and R-R intervals changes), phase (temporal displacement 
of R-R intervals and SBP) and coherence (linear correlation between changes in R-R 
interval and SBP changes) along with spectral power of systolic BP and R-R interval 




6.3 Statistical Analysis  
 
Statistical analysis was performed using IBM SPSS version 26 (SPSS Inc., Chicago, 
IL). Firstly, participants were divided into three age categories: young (18 – 35 years, 
n= 93), middle age (36 – 55 years, n=62) and old age (56 - 70 years, n=51). Between 
age-category differences in baseline characteristics and power spectrum densities 
during squat stand manoeuvres were explored using one-way ANOVA. To examine 
the influence of age, sex, CVD risk and VO2max linear regression was employed. Cross 
sectional associations between age and measures of dCA and cardiac BRS were 
examined using linear regression adjusting for sex (Model 1). Multivariable linear 
regression was used to further adjust for health status (model 2) as well as VO2max 
(model 3).  
Relationship between cardiac BRS and dCA: The linear relationship between cardiac 
BRS and dCA was determined using R2 . For the models, each parameter of cardiac 
BRS was independently used as a predictor variable and each parameter of dCA an 
outcome variable with adjustments for age and sex. Multicollinearity was investigated 











Participant characteristics: There was an increase in SBP, DBP and BMI (P <0.001) 
and decrease in MCAv and VO2max (P <0.001) with age (Table 6.1), with a trend 
towards an inverted-U relationship between PETCO2 and age (P=0.08) 
Table 6.1: Participant characteristics when divided into age categories   












Age (years)  26±5 47±6 61±4  
Male/Female 45/48 18/44 20/31  
SBP (mmHg) 115±11 120±15 138±18 <0.001 
DBP (mmHg) 67±11 73±10 78±10 <0.001 
VO2max 
(ml.kg.min) 
42.2±10.8 28.6±7.4 23.7±5.2 <0.001 
BMI (kg/m2) 24±3 27±6 29±5 <0.001 
MCAv (cm.s) 67±13 64±13 56±13 <0.001 
PETCO2 (mmHg) 36.8±4.3 37.9±4.8 35.9±4.9 0.08 
 
Data presented as mean±SD. Abbreviations; SBP, systolic blood pressure; DBP, 
diastolic blood pressure; BMI, body mass index; MCAv, middle cerebral artery 
velocity; PETCO2 , partial pressure of end tidal carbon dioxide; ANOVA, analysis of 
variance 
 
dCA: Age, sex, CVD risk factors and VO2max do not impact on the dCA parameters 
normalised gain, phase or coherence with minimal change (β) compared to the young 
aged reference group (18-35 yrs) in all statistical models (P>0.05, Table 6.2). There 
was a significant reduction in dCA gain with age, which was apparent when adjusted 
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for sex and CVD risk factors (young – middle age; β = -0.09, P = 0.02 and young - old 
age; β = -0.18, P <0.001, model 2) but not when adjusted for VO2max (model 3).  
BRS: Cardiac BRS gain was attenuated with age when adjusted for sex and CVD risk 
factors (young – middle age; β = -2.18, P <0.001 and young - old age; β = -2.86 P 
<0.001, model 2) along with cardiac BRS phase (young – middle age; β = -0.31, P 
<0.001 and young - old age; β = -0.44 P <0.001, model 2) but not adjusted for VO2max 
(model 3). 
Power spectral analysis: When divided into age categories, dCA BP power, MCAv 
power and cardiac BRS R-R interval power all decreased with age (P<0.001) with no 
difference in SBP power (P=0.55, Table 6.3).  
Relationship between cardiac BRS and dCA: There was no correlation between dCA 
normalised gain and dCA phase with either parameter of cardiac BRS (P >0.05; Figure 
6.1), but dCA gain shows a significant inverse relationship. dCA gain was correlated 
with cardiac BRS gain (R2 = 0.19, P <0.001) and with cardiac BRS phase (R2 = 0.18, 
P <0.001). However, the total variance explained in these significant outcomes is small, 
meaning that other factors are likely to be important, whether independent or as 
interacting variables.    
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 Table 6.2: Cross sectional associations betw
een age and both dCA
 and cardiac BRS during 0.10 H
z squat stand m
anoeuvres.  
               
The regression coefficient β represents the change in the param
eter from
 either young (15-35  yrs)-m
iddle (36-55 yrs) aged or from
 young-old (56-
70 yrs) aged w
hen accounting for m
odel covariates. M
odel 1: A
djusted for sex. M
odel 2: A



















































































































































































































































Table 6.3: Power spectral analysis of both dynamic cerebral autoregulation and 
baroreflex sensitivity during 0.10 Hz squat stand manoeuvers.  
 
 Age categories ANOVA  










Dynamic cerebral autoregulation 
BP power 
(mmHg2) 
215±128 172±105 140±124 0.001  
MCAv power 
(cm/sec2) 




8916±6932 4390±5190 3146±3991 <0.001  
SBP power 
(mmHg2) 
474±368 412±299 470±429 0.55  
 
Values are mean±SD. Abbreviations; BP, blood pressure; MCAv, middle cerebral 

































Figure 6.1: Relationship between dynamic cerebral autoregulation and baroreflex 
sensitivity during 0.10 Hz squat stand manoeuvres. Data presented as individual data 
points with R
2 












6.5 Discussion  
 
The aims of the current study were to (i) examine the impact of sex, cardiorespiratory 
fitness and the presence of CVD risk factors on dCA and cardiac BRS over the life 
span; and (ii) explore the relationships between cardiac BRS and dCA whilst 
controlling for age and sex. The data indicates that dCA, measured using repeated 
squat stand manoeuvres, is not impaired with age, and not impacted by sex, fitness or 
the presence of CVD risk factors. Cardiac BRS was reduced with aging, and displayed 
an inverse relationship with TFA gain, but no relationship with any other parameter 
of dCA. 
Ageing is a well-established principle risk factor for cerebrovascular disease and 
complications. A number of cerebral hemodynamic parameters have been shown to 
change with age, including reductions in CBF volume and CBFv (Krejza et al., 1999, 
Ainslie et al., 2008b), yet the data from the current study suggest that the intrinsic 
ability of cerebral vessels to maintain stable flow despite changes in BP appears to be 
unaffected by ageing. The ability of the cerebrovasculature to buffer these changes in 
BP represents a vital defence mechanism protecting the brain (Claassen and Zhang, 
2011), and data from this present study is in agreement with that of smaller previous 
studies which identified no reduction in dCA with ageing using both squat stand 
manoeuvres (Oudegeest-Sander et al., 2014, Smirl et al., 2014a, Xing et al., 2017) or 
other dCA techniques (Carey et al., 2000, Yam et al., 2005, Dineen et al., 2011). The 
data presented in this study extends these findings of preserved dCA with ageing, 
showing that dCA is not different between sexes when age is considered, and is also 
unaffected by CVD risk factors during low frequency squat stand manoeuvres.  With 
the cohort of participants and based on the risk factors included within this study, no 
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evidence of any decline in dCA with increased risk of CVD was observed. Central 
obesity, hypertension, hypercholesterolemia and T2DM represent major risk factors 
in the development of systemic vascular disease and complications (Seven, 2015) 
including significantly increased risk of cerebrovascular disease (Pinto et al., 2004, 
Kivipelto et al., 2005, Law et al., 2009). Each risk factor, individually or collectively 
is associated with endothelial dysfunction, increased arterial stiffness, alongside a 
range of other vascular abnormalities (Stapleton et al., 2008). Despite these vascular 
changes, no reduction in dCA was identified when using forced BP oscillations 
induced by squat stand manoeuvres. In chapter 3, a small sample of individuals with 
increased CVD risk had a similar dCA to young healthy individuals, with this present 
study confirming the original observation but on a larger scale. To date, no other 
studies have assessed dCA in a population at high risk of CVD. Studies utilising the 
same dCA methods have observed no difference in patients with chronic obstructive 
lung disease (Lewis et al., 2019) or in early stage Alzheimer’s (Claassen et al., 2009a). 
Collectively, the data from this study suggests that despite the vascular 
maladaptation’s that are associated with CVD risk factors, the intrinsic ability of the 
cerebral blood vessels to maintain stable flow is persevered.               
Elevated cardio-respiratory fitness is associated with increased resting CBFv values 
(Ainslie et al., 2008b) and better CVR (Bailey et al., 2013), but its association with 
dCA is less conclusive. We have provided evidence that indicates that those 
individuals with increased cardio-respiratory fitness (VO2max) do not have an 
improved ability to counteract acute, large changes in BP. Interestingly, two previous 
studies concluded higher VO2max was related to attenuated dCA (Lind-Holst et al., 
2011, Labrecque et al., 2017) whereas, Aengevaeren et al. (2013) identified no effect 
of VO2max on dCA. Disparities in results are likely down to differences in dCA 
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assessment methods, further stressing the importance of following previously 
published guidelines (Claassen et al., 2016). This current study has provided evidence 
in a demographically varied cohort, using a single method of dCA assessment with 
TFA, suggesting that better VO2max does not translate to enhanced dCA. The 
physiological connection between VO2max and dCA is unknown but likely to be a 
complex multifactorial relationship. Indeed, increased VO2max is associated with lower 
stroke risk (Lee and Blair, 2002), improved cognition (Brown et al., 2010) and all 
round lower mortality risk from CVD (Kodama et al., 2009), therefore raising the 
concern that either dCA mechanisms are unrelated to such clinical events, or the use 
of TCD and TFA parameters are not sufficient enough to categorically understand 
dCA.  
Data from this study further supports a wealth of research that shows cardiac BRS 
declines with age (Monahan, 2007, Smirl et al., 2014a, Xing et al., 2017). Similarly, 
the data in this present study provides additional evidence that CVD risk factors are 
linked to reduced cardiac BRS (Skrapari et al., 2007, Madden et al., 2010, Sakamoto 
et al., 2019). The relationship between dCA and cardiac BRS however, has proven 
complex. Understanding whether enhanced BP control leads to better control of CBF 
or vice visa is of importance in understanding how these regulatory mechanisms 
operate, and whether they should be the focus of interventions. The maintenance of 
BP and CBF with postural changes, and thus the avoidance of dizziness or syncope, 
depends on the action of baroreflexes to compensate (James and Potter, 1999). 
Additionally, having an efficient and fast acting BP control (cardiac BRS) could 
potentially limit BP fluctuations that are thus transferred into the cerebral vascular 
system.  This present study provides evidence showing that cardiac BRS parameters 
show no relationship with dCA normalised gain and dCA phase during forced BP 
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oscillations, but does appear to have a relationship with dCA (absolute) gain. This 
relationship demonstrates that a reduced cardiac BRS gain and BRS phase is 
associated with a reduced dCA (absolute) gain. This implies that the lower an 
individual’s BRS (i.e. reduced BP control), the more efficient their dCA is at 
counteracting large fluctuations in BP.  As previously mentioned, it is important to 
consider that the parameter of gain reflects the absolute change in CBFv, whereas 
when normalised to account for baseline CBFv and BP (normalised gain) (van Beek 
et al., 2008) no relationship was present. Therefore, the data in this study outlines that 
despite having a significantly greater BP control at a younger age, this does not alter 
how well the cerebral vessels regulate blood flow during BP challenges. Nevertheless, 
an inverse relationship between dCA (absolute) gain and cardiac BRS is not 
completely surprising, given that one previous study using TCD to measure rate of 
regulation and autoregulation index for dCA, and the modified Oxford technique to 
estimate BRS identified an inverse relationship between the two processes (Tzeng et 
al., 2010). On the other hand, previous studies utilising the same methods adopted in 
this present chapter concluded no relationship between dCA and BRS parameters 
(Aengevaeren et al., 2013, Smirl et al., 2014a). Referring back to the original Lassen 
curve of CA, CBF remained largely constant independent of BP changes between 60 
to 150 mmHg (Lassen, 1959), although this is an often challenged observation (Lucas 
et al., 2010, Tan, 2012). To what extent a plateau region of CBF over a given change 
in BP remains elusive. However, if a plateau region does exists or is similar to that 
outlined by Lassen (1959), this indicates that the baroreflex, as an important 
mechanism controlling short-term BP regulation may have negligible input in 
regulation short term CBF (Tzeng et al., 2010).  Identifying the fundamental 
relationship between this functional role of the cardiac baroreceptors and  dCA is of 
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clinical significance, primarily because baroreflex impairment is an adverse 
prognostic indicator for both cardiac and cerebrovascular disease (Tzeng et al., 2010).    
6.6 Conclusion 
 
In conclusion, this study has provided data from a wide cohort of participants, which 
shows that dCA remains intact during the ageing process of 18-70 years. The data 
presented in this study suggests that common risk factors for CVD are not impairing 
dCA and that having increased cardio-respiratory fitness does not translate to more 
efficient dCA. Finally, this present study shows that there is a relationship between 
cardiac BRS and dCA (absolute) gain, and that this relationship implies that a reduced 
cardiac BRS is associated with an enhanced dCA, but this relationship is not present 













































7.1 Aims of the thesis  
 
The work described in the present thesis was designed to investigate the impact of 
rIPC, using acute (one bout) of rIPC as well as repeated bouts for 7 days daily and 8-
week (3 x per week), on both peripheral and cerebrovascular function in individuals 
at risk of CVD. Given the lack of change in cerebral autoregulation as an early marker 
of cerebrovascular function with the interventions implemented within this thesis, the 
final study was designed to investigate whether age, sex, cardiorespiratory fitness or 
CVD risk factors affected cerebral autoregulation.   
 
7.2 Summary of Major Findings 
 
The novel work undertaken in this thesis has generated new knowledge for the 
literature and for clinical practice. The main findings of this thesis are: 
1. In chapter 3, a single bout of rIPC did not influence CBFv or cerebrovascular 
function acutely in healthy individuals, or those at increased CVD risk. 
2. Chapter 4 demonstrated that in a randomised pilot study, the directional changes 
suggest peripheral vascular endothelial function can be enhanced with 7-day daily 
rIPC in T2DM. 
3. Chapter 5 identified that combining aerobic exercise with rIPC for 8 weeks does not 
mediate greater changes in cerebral and peripheral vascular function compared to a 
rIPC only intervention.  
4. In chapter 6, dCA measured using squat stand manoeuvres and TFA was unaffected 
by age, CVD risk factors and cardio-respiratory fitness and operates independent of 




7.3 General discussion of major findings  
 
7.3.1 The Dose of rIPC 
 
rIPC can be administered as a single dose (i.e. 4 x 5 min bouts of forearm ischemia 
and reperfusion) and has shown cardioprotective benefits in the myocardium and the 
peripheral vasculature (Botker et al., 2010, van den Munckhof et al., 2013). Increasing 
the ‘dose’ of rIPC by simply increasing the amount of times the ischemia-reperfusion 
cycles are applied was investigated throughout the current thesis. The data from this 
thesis suggests that increasing the dose of rIPC by either increasing the number of 
bouts (chapters 4 and 5) and/or or combing with a potentially mutually beneficial 
intervention of exercise training (chapter 5) has little impact on improving peripheral 
vasculature or cerebrovascular outcomes in individuals with CVD risk factors.  
One of the novel aspects of this thesis was to examine the impact of rIPC on the 
cerebrovasculature. Chapter 3 suggested that an acute bout of rIPC had no immediate 
(i.e. during the first window of protection) effect on cerebrovascular function. Whilst 
an acute bout of rIPC has been shown previously to have a positive impact on 
endothelial IR injuries in older individuals and those with congestive heart failure (van 
den Munckhof et al., 2013, Kono et al., 2014, Thijssen et al., 2016a), there is evidence 
to suggest that there is also little impact on vascular function measured using the FMD 
technique (Enko et al., 2011, Moro et al., 2011), so no acute effect may not be 
surprising. Nevertheless, increasing the dose by performing more bouts of rIPC over 
days (chapter 4) or weeks (chapter 5) also had little impact on cerebrovascular function. 
In the present thesis the largest dose was administered in chapter 5, the dose of rIPC 
was 3 x per week, thus 24 bouts in total over an 8 week period. In comparison to the 
previous studies which have observed improvements in cerebrovascular markers and 
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stroke reoccurrence with daily and/or twice daily rIPC bouts over a longer intervention 
period (~ 300 individual bouts) (Meng et al., 2012, Meng et al., 2015, Mi et al., 2016, 
Wang et al., 2017) the dose applied in the current thesis is still a relatively small. 
Therefore, research studies exploring the impact of larger rIPC doses (duration of 
intervention and frequency of bouts) or investigating the optimal dose are required to 
further explore the impact of rIPC of cerebrovascular health.  
Large doses of rIPC have typically been employed to improve parameters of the 
cerebral circulation but smaller doses (duration of intervention and frequency of bouts) 
have been shown to be effective in the peripheral vasculature. Chapter 5 in the present 
thesis supports that of two previous studies which show that FMD can be improved in 
as little as 7 days (7 rIPC bouts) (Luca et al., 2013, Jones et al., 2014) in individuals 
with T2DM that likely have vascular dysfunction. Smaller doses of rIPC have also 
elicited improvements in FMD with in healthy individuals, Jones et al. (2015) 
demonstrating that 6 bouts spread over two weeks as well as 24 bouts (3 x per week 
for 8 weeks) of rIPC also results in enhanced FMD. It is plausible that individuals with 
vascular dysfunction may require a larger dose of rIPC to show changes in vascular 
function and further research studies examining this concept or warranted. 
Interestingly, the ability of rIPC to provide protection against a temporary endothelial 
IR injury was not consistent within this thesis, whereas a small number of studies have 
observed sustained protection from rIPC to the same IR injury model used in this thesis 
(Kharbanda et al., 2001, Kharbanda et al., 2002, Luca et al., 2013). In Chapter 4, 
following 1 week of daily rIPC, the dysfunction following an IR injury was reduced 
compared to that of pre intervention values. However, in study 5, with 3 rIPC bouts 
per week for 8 weeks, post IRI FMD was unchanged following both interventions. 
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Such findings further support the call for future research to target identifying the 
optimal dose of rIPC.   
To what extend the proximity of the stimulus to the target area is unknown. Whether 
rIPC applied to a limb, as was the case throughout this thesis, is too far away from 
target area (cerebral blood vessels) may be a potential explanation to the lack of 
adaptation from rIPC in chapters 3, 4 and 5 of this thesis. On the other hand, given the 
growing body of evidence suggesting that rIPC induces humoral and neural factors 
that translate into systemic changes/adaptations (Heusch et al., 2015, Thijssen et al., 
2016a), the site/location in which the rIPC is applied should not necessarily determine 
the extent of protection or adaption in the target area. Intriguingly, evidence from a 
rodent model showed that direct IPC was less effective and providing protection 
against renal IR compared to rIPC (Oral et al., 2018). Furthermore, human studies, 
including the data from chapter 4 of this thesis, have shown no difference between 
remote and local IPC (Jones et al., 2014) in the peripheral vascular beds but to do what 
extent this also applied to the cerebral vascular bed in unknown, and is likely to be 
limited to animal models. Alternative strategies to induce IPC-like stimulus in terms 
of the fluctuations blood flow and shear stress patterns may be of potential interest 
including; cold exposure  (Brown et al., 2003), hypoxia (Harris et al., 2013) and water 
immersion  (Carter et al., 2014a) certainly warrant further investigation. 
7.3.2  rIPC in clinical populations 
 
An important consideration when executing any intervention is the population who 
are targeted. Numerous rIPC interventions have focused on individuals who are 
deemed fit and healthy with no current health risk (Kimura et al., 2007, Luca et al., 
2013, Jones et al., 2014, Jones et al., 2015, Lindsay et al., 2017) or with various 
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diseases (Meng et al., 2012, Liang et al., 2015, Meng et al., 2015, Pryds et al., 2017, 
Wang et al., 2017) with few studies aimed at those individuals deemed at risk. Whether 
the effectiveness of rIPC is influenced by the health status of an individual, or the 
health of the endothelium is unclear. Therefore, the individuals primarily targeted 
within the current thesis were those who are deemed at risk of CVD, therefore 
examining the impact of rIPC as an early intervention to improve vascular health and 
reduce disease risk was a primary focus. A recent study in hypertensive patients 
suggested that 30 days of daily rIPC (30 bouts) was successful in reducing BP and also 
improved micro-vessel endothelial function, thus reducing their risk of hypertension 
complications (HyTong et al., 2019). Interestingly such reductions in BP were not 
evident in chapters 4 and 5 of this thesis, but in chapters 4 and 5 the total dose and 
rIPC was lower and not all individuals were hypertensive nor had any know 
cardiovascular or cerebrovascular disease. Taken together, it is possible that those 
individuals diagnosed with a CV disease (e.g. hypertension) or post CV event (e.g. 
stroke) may benefit the most from a rIPC intervention (of a big enough dose). Future 
studies examining the effectiveness of rIPC interventions in healthy, at risk of CVD, 
with overt risk factors and with CVD or cerebrovascular disease are required.   
 
7.3.3 Interventions and cerebrovascular function 
 
Interventions that target CBF and cerebrovascular function are of paramount 
importance in preventing and treating cerebrovascular health, cognitive decline, 
vascular dementia and stroke (Kalaria et al., 2016). Interventions, such as exercise but 
also pharmacological and lifestyle interventions have been implemented targeting the 
improvement of cerebrovascular function but findings on the impact of such 
interventions have been inconsistent as to whether they can improve CBF or 
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cerebrovascular function (Akazawa et al., 2012, Murrell et al., 2013, Drapeau et al., 
2019, Lewis et al., 2019). In the present thesis the addition of exercise to the rIPC 
intervention in chapter 5 did not mediate any changes in the cerebrovascular function. 
Exercise improves systemic cardiovascular function, but specific to the brain exercise 
is thought to increase shear stress and signalling cascades as well as enhances neural 
activation and metabolism (Lucas et al., 2015). As outlined in earlier chapters, to the 
best of our knowledge no study to date has reported an improved dCA measured using 
TFA following an exercise training intervention. Cross-sectional studies have 
identified no beneficial adaptations to dCA with habitual exercise training 
(Aengevaeren et al., 2013, Perry et al., 2019). Acute exercise elicits increases in CBF 
up to around 70% VO2max before hyperventilation  induced hypocapnia either plateaus 
or reduces CBF (Lucas et al., 2015, Smith and Ainslie, 2017). These increases in blood 
flow and shear stress patterns may contribute to enhanced cerebrovascular function 
through improved endothelium function (Smith et al., 2019), but the extent to which 
this can contribute to enhanced dCA remains unanswered.   
An additional factor which must be considered when assessing cerebrovascular 
function using dCA is what exactly an improved dCA presents itself as. Classically, 
the consensus has focused on improved dCA would be represented by TFA as reduced 
gain and/or improved phase (van Beek et al., 2008, Claassen et al., 2016), however 
given the lack of  published data that shows any improvements in dCA using similar 
techniques (squat-stand manoeuvres and TFA) adopted throughout this thesis, a lot of 
questions remained unanswered. Theoretically, the argument could be made that for 
dCA to truly be improved both parameters (gain and phase) should display 
improvements and physiologically they may be true. If an individual improves the 
temporal alignment of BP-CBF oscillations (phase) – this could in turn result in a 
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reduced BP-CBF magnitude (gain).  Nevertheless, this all remains speculative and 
future work is required to accurately understand the metrics of dCA with TFA, 
outlining if the metrics are associated with each other, and if one parameter of dCA is 
more physiologically ‘important’ than another.               
Given the lack of consistent changes in exercise and lifestyle interventions on 
cerebrovascular function it might not be surprising that a rIPC intervention did not 
mediate a beneficial effect.   One the other hand, given the previous remarkable finding 
in stroke patients of increased CBF, reduced stroke recurrence and decreased white 
matter hyperintensities (Meng et al., 2012, Meng et al., 2015, Mi et al., 2016, Wang et 
al., 2017), then one might expect some functional cerebrovascular changes. The 
experimental studies in this thesis attempted to extend the understanding of rIPC by 
investigating functional parameters of the cerebral circulation, to try and understand 
how rIPC may elicit such adaptations. The data from these chapters show that rIPC 
did not alter CBFv or any of the aspects of cerebrovascular function. As discussed 
above this could be explained by rIPC dose or evidence of disease but one other 
potential explanation could be related to how cerebrovascular function was assessed 
in the current thesis.    
7.3.4 Measurements of cerebrovascular function 
 
TCD offers a non-invasive and high temporal resolution measurement technique for 
the assessment of CBFv and together with measurements of BP, expired CO2 and 
neural activity can provide information on cerebrovascular function. Throughout this 
thesis, TCD was utilised to assess cerebrovascular function using a number of 
assessment techniques set out by Willie et al. (2011). The measurement of dCA was 
performed throughout all experimental studies in this thesis as well as being the 
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primary focus in chapter 6. dCA represents an essential protective mechanism 
ensuring stable blood flow to the brain (van Beek et al., 2008), therefore maintaining 
good or even improving dCA is likely to be of benefit. Measurement and assessment 
of dCA however is not straightforward and whilst attempts have been made in order 
to standardise measurement techniques when using TCD together with BP to 
understand cerebral autoregulation and to improve repeatability (Claassen et al., 2009b, 
Meel-van den Abeelen et al., 2014, Claassen et al., 2016, Simpson and Claassen, 2018), 
there still appears to be a range of measurement technique in the literature.. It is 
possible that these techniques or protocols are not sensitive enough to assess changes 
in dCA. It is noteworthy that in an attempt to obtain a more rounded dCA profile, in 
chapter 5 assessment of MCAv in response to spontaneous BP fluctuations was also 
included in the testing protocol alongside the forced BP oscillation in the squat stand 
manoeuvres. Nevertheless as seen in chapter 5, neither measurements of 
autoregulation were changed following either intervention.        
In chapters 3, 4 and 5, none of the interventions used mediated any change in dCA. 
Whilst this could be as a direct consequence of the intervention, it is also possible that 
either the physiological variable being targeted is not responsive to the intervention 
and /or the measurement technique is insensitive. As previously mentioned throughout 
the thesis, there is consistent evidence of impairment in peripheral vascular function 
with CVD risk, yet no such evidence is available regarding dCA, a key homeostatic 
mechanism. The results from chapter 6 suggest that CVD risk factors are not 
influencing dCA when assessed using squat stand and TFA and that ageing does not 
alter dCA from 18-70 years. Based on the findings from this chapter, should dCA be 
a target for interventions if it is not impaired with ageing (unlike CBF). There are also 
studies that have utilised the same squat stand protocol with TFA as employed within 
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the current thesis that show no impairment in dCA in heart transplant recipients (Smirl 
et al., 2014a), chronic obstructive lung disease (Lewis et al., 2019) or stage 2 
Alzheimer’s (Heus et al., 2018). Future research studies are required to examine the 
sensitivity of these techniques in assessing dCA or alternative measurement 
techniques or protocols need to be developed to understand changes in cerebral 
autoregulation with age and/or intervention.  
7.4 Methodological Considerations and Limitations  
 
There are a number of strengths in the methodology of this thesis. The participants 
recruited for each of the experimental studies in this study give a good representation 
of the general population in the UK. Chapters 3, 4, 5, and 6 all contain individuals 
with established risk factors for CVD, chapter 4 focuses on individuals diagnosed with 
T2DM and chapters 3 and 6 also included a cohort of both young and old healthy and 
active individuals. Based on this, the findings presented from this thesis are applicable 
to a wide cohort and not limited to one participant group.  
Each study of this thesis ensured strict inclusion and exclusion criteria in addition to 
the control of diet and exercise prior to and during laboratory visits. Importantly, each 
measurement applied within this thesis was performed adhering to the most recent 
published guidelines for that specific measurement. For example, FMD assessments 
were undertaken according to the latest peer-reviewed consensus guidelines (Thijssen 
et al., 2011a), together with the use of custom-designed edge-detection and wall-
tracking analysis software, the accuracy, validity and prognostic value of FMD 
outcomes were maximised. dCA measurements were all performed following cerebral 
autoregulation network recommendations (Claassen et al., 2016). Another major 
strength to the work contained within this thesis was the research design of the 
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experimental studies. Chapters 3 and 5 include intervention trials including an 8 week 
intervention, and chapter 4 included a randomised control trial. Lastly, chapter 6 
included a relatively large sample size, incorporating a demographically varied cohort 
of individuals in an in order to describe changes in dCA and BRS.  
Despite these methodological strengths, there are a number of limitations contained. 
The most notable limitation within this thesis is the use of TCD for the measurement 
of CBF and cerebrovascular function. As is frequently discussed in a number of 
reviews (Willie et al., 2011, Ainslie and Hoiland, 2014), TCD provides measurement 
of CBFv as an index of CBF, as TCD does not provide feedback regarding vessel 
diameter. Changes in vessel diameter can affect measurement accuracy of CBF with 
TCD (Heus et al., 2018). CBFv is an adequate surrogate of absolute flow only if the 
insonated vessel maintains constant vessel diameter across time and experimental 
conditions (Ainslie and Hoiland, 2014), and it is unlikely that acute rIPC induced a 
vessel diameter change, but chronic diameter changes connect be excluded. The use 
of additional imaging techniques such as MR arterial spin labeling, SPECT, and 
Xenon-CT would overcome such limitations, however their temporal resolution is 
currently too low to assess the dynamics of dCA (Heus et al., 2018) and they are either 
expensive or invasive techniques. The MCA diameter is unlikely to change under 
resting conditions or during moderate changes in BP (Serrador et al., 2000), similar to 
that induced during repeated squat stand manoeuvres. MCA diameter alterations in 
responses to changes in blood CO2 content remains a highly controversial topic 
(Brothers and Zhang, 2016, Hoiland and Ainslie, 2016). Previous work utilising MRI 
identified that with increases of PETCO2  of  ≈8 mmHg MCA diameter remains 
unchanged (Serrador et al., 2000), however more recent studies using higher resolution 
MRI ( 3 and 7 Tesla) have shown both dilation and constriction of the MCA during 
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hyper- and hypocapnia (Coverdale et al., 2014, Verbree et al., 2014, Coverdale et al., 
2015). Certain studies have highlighted that MCA diameter may remain constant 
during modest changes in PETCO2 but no definitive threshold has yet been described 
(Verbree et al., 2014). Based on this uncertainty it is important to acknowledge that 
the MCAv data during hypercapnia may have underestimated flow as a result of 
potential MCA diameter changes.    
The model employed to induce a temporary endothelial IR injury in chapters 4 and 5 
is used only as a surrogate index to cardiac tissue. Nonetheless, this is a frequently 
used model to assess endothelial ischemia reperfusion injuries in research studies (van 
den Munckhof et al., 2013, Carter et al., 2014b, Thijssen et al., 2019a). Moreover, 
applying this technique significantly decreases plasma nitrite and plasma nitrate 
concentrations, indicating that any change in endothelial IR injury is due to a reduction 
in NO bioavailability (Aboo Bakkar et al., 2018) and thus provides some mechanistic 
insight.  
In chapter 6, whilst the study sample size was the largest to describe dCA to date, there 
are still some weaknesses/limitations of the study. Cross sectional study designs are 
limited in their ability to confirm causality/mechanisms. Additionally, despite the 
sample size being relatively large, it is still possible that the data lacked the statistical 
power to detect differences due to effect sizes of the measurements included.    
 
7.5 Recommendations for clinical practise and future studies 
 
Whilst the phenomenon of IPC has come a long way since it was first identified by 
Murry et al in 1986, it still has some way before it is implemented clinically. This 
thesis aimed to answer questions regarding the impact of rIPC as an intervention in 
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individuals at risk of CVD and explore its effects on systemic vascular function. rIPC 
has the potential to offer a relatively low cost, non-invasive and easily applicable 
intervention to improve a range of parameters of cardiovascular health. Given the 
improvements in peripheral vascular function in chapter 4 and because endothelial 
dysfunction represents a significant event in the atherosclerotic cascade and predicts 
cardiovascular and cerebrovascular events (Inaba et al., 2010). The findings from 
chapter 4 suggest that rIPC has the potential to improve endothelial function in a 
patient group with likely endothelial dysfunction and at higher risk of vascular 
complications.  
 
It is too soon to recommend rIPC interventions for routine clinical practice based on 
the research evidence form this thesis and literature to date. Numerous, large scale 
phase II, III and IV clinical trials are required in a variety of clinical cohorts to truly 
understand the effects of the interventions and to gain better insight into the 
mechanisms mediating such changes. Nevertheless, based on the evidence presented 
in this thesis, below are the key areas in which future studies can build upon the work 
presented here. 
1. Aim to identify the optimal dose of rIPC in terms of duration (e.g. weeks or 
months) and frequency (e.g. daily or weekly). By designing large scale trials 
with a range of different rIPC intervention protocols, this should in turn 
identify the most effective rIPC protocol which is a crucial step should rIPC 
be implemented clinically.  
2. Establish whether similar to exercise, rIPC exerts it effects differently 
depending on health status. Expanding on the work contained within this thesis, 
future research should open up to exploring the rIPC effects on a broad range 
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of clinical groups, and gain an understanding of how different clinical 
conditions respond differently.     
3. Attempt to further understand the mechanism mediating the rIPC adaptations. 
By designing mechanistic focused studies, future work should aim to identify 
the mechanisms involved in the protective effects of rIPC as well as its 
association with enhanced vascular function.     
4. Building on chapter 4, future trials with adequate statistical power are required 
to identify if rIPC has the ability to improve vascular outcomes in T2DM. 
Chapter 4 has laid the foundations for a large scale clinical trial by 
demonstrating the positive directional changes in vascular function in a pilot 
study. Future randomised control trials, which a sufficiently powered 
statistically should focus on rIPC in T2DM.   
5. Based on the findings in chapter 6, further understanding of factors that can 
influence dCA and identify in what disease states dCA is impaired or 
attenuated. By exploring dCA in a range of clinical groups, not just limited to 
CVD risk as in this thesis, researchers will be able to identify when it is 
impaired, which may then potentially assist in understanding the exact 
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